F6publishing.blob.core.windows.net



Name of Journal: World Journal of Clinical CasesManuscript NO: 42765Manuscript Type: ORIGINAL ARTICLERandomized Clinical TrialSafety of applying midazolam-ketamine-propofol sedation combination under the supervision of endoscopy nurse with patient-controlled analgesia pump in colonoscopyKayaalt? S et al. Safety of colonoscopy sedation by endoscopy nurseSelda Kayaalt?, ?mer Kayaalt?Selda Kayaalt?, Division of Anaesthesiology and Reanimation, Develi Public Hospital, Kayseri, Develi 38440, Turkey ?mer Kayaalt?, Computer Technology, Kayseri University, Develi Huseyin Sahin Vocational College, Kayseri, Develi 38440, TurkeyORCID number: Selda Kayaalt? (0000-0002-8176-0188); ?mer Kayaalt? (0000-0002-1630-1241).Author contributions: Kayaalt? S designed and performed research; Kayaalt? S and Kayaalt? ? analyzed data, wrote the paper and reviewed manuscript.Institutional review board statement: This study was reviewed and approved by the ethics committee of Erciyes Nuiversity Medical Faculty.Clinical trial registration statement: The registration identification number is 2018/rmed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous data that were obtained after patient agreed to treatment by written consent.Conflict-of-interest statement: The author declared no conflicts of interest with respect to the authorship and/or publication of this article.Data sharing statement: No additional data are available.CONSORT 2010 statement: The authors have read the CONSORT 2010 Statement, and the manuscript was prepared and revised according to the CONSORT 2010 Statement.Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: HYPERLINK "" source: Unsolicited manuscriptCorresponding author to: Selda Kayaalt?, MD, PhD, Doctor, Specialist Doctor, Division of Anaesthesiology and Reanimation, Develi Public Hospital, Camicedit Mah. Hastane Cad. No: 14, Kayseri, Develi 38440, Turkey. drselda@Telephone: +90-352-6216020Fax: +90-352-6216223Received: October 9, 2018Peer-review started: October 10, 2018First decision: November 1, 2018 Revised: November 9, 2018Accepted: November 23, 2018Article in press: Published online:AbstractAIMTo compare the results of midazolam-ketamine-propofol sedation performed by endoscopy nurse and anaesthetist during colonoscopy in terms of patient satisfaction and safety.METHODSAmerican Statistical Association (ASA) I-II 60 patients who underwent colonoscopy under sedation were randomly divided into two groups [sedation under the supervision of anaesthetist (SSA) and sedation under the supervision of endoscopy nurse (SSEN)]. Both groups were initially administered 1 mg of midazolam, 50 mg of ketamine and 30-50 mg of propofol. Continuation of sedation was performed by the anaesthetist in the SSA group and the nurse with patient-controlled analgesia (PCA) pump in the SSEN group. The total propofol consumption, the duration of the procedure, recovery times, the pain [visual analogue scale (VAS)] and satisfaction score of the patients, and side effects were recorded. In addition, the patients were asked whether they remembered the procedure, and whether they would re-prefer the same method in case of re-endoscopy.RESULTS The total propofol consumption in the SSEN group was found to be significantly higher (P???0.05) than that of the SSA group. When the groups were compared in terms of VAS score, recovery time, patient satisfaction, recall of the procedure, re-preference for the same method in case of re-endoscopy, and side effects, there were no significant differences (P > 0.05) between the two groups. Any long-term and requiring intervention side effects were not observed in both groups.CONCLUSIONColonoscopy sedation in ASA I-II patients can be safely performed by an endoscopy nurse using PCA pump with the incidence of side effects and patient satisfaction levels similar to sedation under anaesthetist supervision.Key words: Patient-controlled analgesia pump; Colonoscopy; Nurse-administered sedation; Midazolam-ketamine-propofol combination? The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.Core tip: Sedation is frequently performed during interventional procedures such as colonoscopy. In case there are not enough anaesthetists, there are a variety of sedation protocols also applied by educated non-anaesthesia personnel. In our study, we showed that midazolam-ketamine-propofol combination can be applied under the supervision of an endoscopy nurse.Kayaalt? S, Kayaalt? ?. The safety of applying midazolam-ketamine-propofol sedation combination under the supervision of endoscopy nurse with patient-controlled analgesia pump in colonoscopy. World J Clin Cases 2018; In pressINTRODUCTIONGastrointestinal endoscopy practices have been increasing worldwide. During colonoscopy, patients do not want to be awake because of severe abdominal pain, cramps and bloating as well as embarrassment ADDIN EN.CITE <EndNote><Cite><Author>Ghanouni</Author><Year>2016</Year><RecNum>25</RecNum><DisplayText><style face="superscript">[1]</style></DisplayText><record><rec-number>25</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068436">25</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Ghanouni, Alex</style></author><author>Plumb, Andrew</author><author>Hewitson, Paul</author><author>Nickerson, Claire</author><author>Rees, Colin J</author><author>von Wagner, Christian</author></authors></contributors><titles><title>Patients&apos; experience of colonoscopy in the English Bowel Cancer Screening Programme</title><secondary-title>Endoscopy</secondary-title></titles><periodical><full-title>Endoscopy</full-title><abbr-1>Endoscopy</abbr-1></periodical><pages>232-240</pages><volume>48</volume><number>3</number><dates><year>2016</year></dates><isbn>1438-8812</isbn><urls></urls><custom2>26841268</custom2><electronic-resource-num>10.1055/s-0042-100613</electronic-resource-num></record></Cite></EndNote>[1]. The demand for sedation in colonoscopies is increasing because of the influence of image quality in colorectal cancers and the increase in expectation of painless treatment of patients ADDIN EN.CITE <EndNote><Cite><Author>Ferreira</Author><Year>2015</Year><RecNum>24</RecNum><DisplayText><style face="superscript">[2]</style></DisplayText><record><rec-number>24</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068429">24</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Ferreira, Alexandre Oliveira</style></author><author>Cravo, Marília</author></authors></contributors><titles><title>Sedation in gastrointestinal endoscopy: Where are we at in 2014?</title><secondary-title>World journal of gastrointestinal endoscopy</secondary-title></titles><periodical><full-title>World journal of gastrointestinal endoscopy</full-title><abbr-1>World J Gastrointest Endosc</abbr-1></periodical><pages><style face="normal" font="default" size="100%">102</style><style face="normal" font="default" charset="162" size="100%">-109</style></pages><volume>7</volume><number>2</number><dates><year>2015</year></dates><urls></urls><custom2>25685266</custom2><electronic-resource-num>10.4253/wjge.v7.i2.102</electronic-resource-num></record></Cite></EndNote>[2].A variety of sedation techniques are used during colonoscopy. Sedoanalgesia, deep sedation under the supervision of anaesthetist (SSA), sedation under the supervision of nurse, and computer assisted sedation with target-controlled devices are among these techniques ADDIN EN.CITE <EndNote><Cite><Author>Lin</Author><Year>2017</Year><RecNum>23</RecNum><DisplayText><style face="superscript">[3]</style></DisplayText><record><rec-number>23</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068424">23</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Lin, Otto S</style></author></authors></contributors><titles><title>Sedation for routine gastrointestinal endoscopic procedures: a review on efficacy, safety, efficiency, cost and satisfaction</title><secondary-title>Intestinal research</secondary-title></titles><periodical><full-title>Intestinal research</full-title><abbr-1>Intest Res</abbr-1></periodical><pages>456-466</pages><volume>15</volume><number>4</number><dates><year>2017</year></dates><isbn>1598-9100</isbn><urls></urls><custom2>29142513</custom2><electronic-resource-num>10.5217/ir.2017.15.4.456</electronic-resource-num></record></Cite></EndNote>[3]. Medications used and applied techniques vary from clinic to clinic. The most commonly used agent is the midazolam. It is used alone or in combination with an opioid (meperidine, fentanyl or alfentanyl). The second most frequently used agent is propofol. Propofol may be used alone or in combination with an opioid analgesic agent or midazolam ADDIN EN.CITE <EndNote><Cite><Author>Ferreira</Author><Year>2015</Year><RecNum>24</RecNum><DisplayText><style face="superscript">[2]</style></DisplayText><record><rec-number>24</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068429">24</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Ferreira, Alexandre Oliveira</style></author><author>Cravo, Marília</author></authors></contributors><titles><title>Sedation in gastrointestinal endoscopy: Where are we at in 2014?</title><secondary-title>World journal of gastrointestinal endoscopy</secondary-title></titles><periodical><full-title>World journal of gastrointestinal endoscopy</full-title><abbr-1>World J Gastrointest Endosc</abbr-1></periodical><pages><style face="normal" font="default" size="100%">102</style><style face="normal" font="default" charset="162" size="100%">-109</style></pages><volume>7</volume><number>2</number><dates><year>2015</year></dates><urls></urls><custom2>25685266</custom2><electronic-resource-num>10.4253/wjge.v7.i2.102</electronic-resource-num></record></Cite></EndNote>[2]. Propofol is a short-acting sedative agent without analgesic properties ADDIN EN.CITE <EndNote><Cite><Author>Faulx</Author><Year>2005</Year><RecNum>22</RecNum><DisplayText><style face="superscript">[4]</style></DisplayText><record><rec-number>22</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068420">22</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Faulx, Ashley L</style></author><author>Vela, Stacie</author><author>Das, Ananya</author><author>Cooper, Gregory</author><author>Sivak Jr, Michael V</author><author>Isenberg, Gerard</author><author>Chak, Amitabh</author></authors></contributors><titles><title>The changing landscape of practice patterns regarding unsedated endoscopy and propofol use: a national Web survey</title><secondary-title>Gastrointestinal endoscopy</secondary-title></titles><periodical><full-title>Gastrointestinal endoscopy</full-title><abbr-1>Gastrointest Endosc</abbr-1></periodical><pages>9-15</pages><volume>62</volume><number>1</number><dates><year>2005</year></dates><isbn>0016-5107</isbn><urls></urls><custom2>15990813</custom2><electronic-resource-num>10.1016/S0016-5107(05)00518-3</electronic-resource-num></record></Cite></EndNote>[4]. Therefore, when propofol is used alone, high doses are required to tolerate some invasive procedures. This can lead to life-threatening conditions such as hypotension and respiratory depression ADDIN EN.CITE <EndNote><Cite><Author>Türk</Author><Year>2013</Year><RecNum>21</RecNum><DisplayText><style face="superscript">[5]</style></DisplayText><record><rec-number>21</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068414">21</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Türk, Hacer ?ebnem</style></author><author>Aydo?mu?, Meltem</author><author>?nsal, Oya</author><author>K?ksal, Hakan Mustafa</author><author>A?ik, Mehmet Eren</author><author>Oba, Sibel</author></authors></contributors><titles><title>Sedation-analgesia in elective colonoscopy: propofol-fentanyl versus propofol-alfentanil</title><secondary-title>Revista Brasileira de Anestesiologia</secondary-title></titles><periodical><full-title>Revista Brasileira de Anestesiologia</full-title><abbr-1>Rev Bras Anestesiol</abbr-1></periodical><pages>353-358</pages><volume>63</volume><number>4</number><dates><year>2013</year></dates><isbn>0034-7094</isbn><urls></urls><custom2>23931250</custom2><electronic-resource-num>10.1016/j.bjan.2012.07.006</electronic-resource-num></record></Cite></EndNote>[5]. Adding opioids to the propofol reduces the incidence of side effects and also allows patients to feel less pain during the procedure. It also reduces propofol injection pain ADDIN EN.CITE <EndNote><Cite><Author>Joo</Author><Year>2001</Year><RecNum>20</RecNum><DisplayText><style face="superscript">[6]</style></DisplayText><record><rec-number>20</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068409">20</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Joo, Hwan S</style></author><author>Perks, William J</author><author>Kataoka, Mark T</author><author>Errett, Lee</author><author>Pace, Kenneth</author><author>Honey, R John</author></authors></contributors><titles><title>A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy</title><secondary-title>Anesthesia &amp; Analgesia</secondary-title></titles><periodical><full-title>Anesthesia &amp; Analgesia</full-title><abbr-1>Anesth Analg</abbr-1></periodical><pages>1227-1232</pages><volume>93</volume><number>5</number><dates><year>2001</year></dates><isbn>0003-2999</isbn><urls></urls><custom2>11682403</custom2><electronic-resource-num>10.1097/00000539-200111000-00037</electronic-resource-num></record></Cite></EndNote>[6]. Better results are obtained when combined with propofol and ketamine which provide dissociative anaesthesia ADDIN EN.CITE <EndNote><Cite><Author>Alletag</Author><Year>2012</Year><RecNum>19</RecNum><DisplayText><style face="superscript">[7]</style></DisplayText><record><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068401">19</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Alletag, Michelle J</style></author><author>Auerbach, Marc A</author><author>Baum, Carl R</author></authors></contributors><titles><title>Ketamine, propofol, and ketofol use for pediatric sedation</title><secondary-title>Pediatric emergency care</secondary-title></titles><periodical><full-title>Pediatric emergency care</full-title><abbr-1>Pediatr Emerg Care</abbr-1></periodical><pages>1391-1395</pages><volume>28</volume><number>12</number><dates><year>2012</year></dates><isbn>0749-5161</isbn><urls></urls><custom2>23222112</custom2><electronic-resource-num>10.1097/PEC.0b013e318276fde2</electronic-resource-num></record></Cite></EndNote>[7]. Both fentanyl and ketamine provide anaesthesia, analgesia, and anxiolysis. The delayed peak levels and prolonged duration of action of fentanyl are significant disadvantages. After intravenous administration, it reaches its peak level in 4-6 min and its duration of action ends in 20-40 min. Ketamine also has a good safety profile with the advantage of preserving spontaneous breathing and protective airway reflexesPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HcmVlbjwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJl

Y051bT40MDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPls4

LCA5XTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQwPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZy

NnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1NDE2MTM5NzMiPjQwPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVm

YXVsdCIgc2l6ZT0iMTAwJSI+R3JlZW4sIFN0ZXZlbiBNPC9zdHlsZT48L2F1dGhvcj48YXV0aG9y

PktyYXVzcywgQmFydWNoPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+

PHRpdGxlPkNsaW5pY2FsIHByYWN0aWNlIGd1aWRlbGluZSBmb3IgZW1lcmdlbmN5IGRlcGFydG1l

bnQga2V0YW1pbmUgZGlzc29jaWF0aXZlIHNlZGF0aW9uIGluIGNoaWxkcmVuPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkFubmFscyBvZiBlbWVyZ2VuY3kgbWVkaWNpbmU8L3NlY29uZGFyeS10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Bbm5hbHMgb2YgZW1lcmdlbmN5IG1l

ZGljaW5lPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW5uIEVtZXJnIE1lZDwvYWJici0xPjwvcGVyaW9k

aWNhbD48cGFnZXM+NDYwLTQ3MTwvcGFnZXM+PHZvbHVtZT40NDwvdm9sdW1lPjxudW1iZXI+NTwv

bnVtYmVyPjxkYXRlcz48eWVhcj4yMDA0PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDE5Ni0wNjQ0PC9p

c2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4yMTI1NjYyNTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTAxNi9qLmFubmVtZXJnbWVkLjIwMDQuMDYuMDA2PC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5TdHJheWVyPC9BdXRo

b3I+PFllYXI+MjAwODwvWWVhcj48UmVjTnVtPjM5PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJl

cj4zOTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncw

d3N2cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTQxNjEzODg2Ij4z

OTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJv

bGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPlN0cmF5ZXIsIFJldWJlbiBKPC9zdHlsZT48

L2F1dGhvcj48YXV0aG9yPk5lbHNvbiwgTGV3aXMgUzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRy

aWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5BZHZlcnNlIGV2ZW50cyBhc3NvY2lhdGVkIHdpdGgga2V0

YW1pbmUgZm9yIHByb2NlZHVyYWwgc2VkYXRpb24gaW4gYWR1bHRzPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPlRoZSBBbWVyaWNhbiBqb3VybmFsIG9mIGVtZXJnZW5jeSBtZWRpY2luZTwvc2Vjb25k

YXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlRoZSBBbWVyaWNhbiBq

b3VybmFsIG9mIGVtZXJnZW5jeSBtZWRpY2luZTwvZnVsbC10aXRsZT48YWJici0xPkFtIEogRW1l

cmcgTWVkPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz45ODUtMTAyODwvcGFnZXM+PHZvbHVt

ZT4yNjwvdm9sdW1lPjxudW1iZXI+OTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA4PC95ZWFyPjwv

ZGF0ZXM+PGlzYm4+MDczNS02NzU3PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xOTA5MTI2

NDwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9qLmFqZW0uMjAwNy4x

Mi4wMDU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5HcmVlbjwvQXV0aG9yPjxZZWFyPjIwMDQ8L1llYXI+PFJl

Y051bT40MDwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPls4

LCA5XTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjQwPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZy

NnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1NDE2MTM5NzMiPjQwPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVm

YXVsdCIgc2l6ZT0iMTAwJSI+R3JlZW4sIFN0ZXZlbiBNPC9zdHlsZT48L2F1dGhvcj48YXV0aG9y

PktyYXVzcywgQmFydWNoPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+

PHRpdGxlPkNsaW5pY2FsIHByYWN0aWNlIGd1aWRlbGluZSBmb3IgZW1lcmdlbmN5IGRlcGFydG1l

bnQga2V0YW1pbmUgZGlzc29jaWF0aXZlIHNlZGF0aW9uIGluIGNoaWxkcmVuPC90aXRsZT48c2Vj

b25kYXJ5LXRpdGxlPkFubmFscyBvZiBlbWVyZ2VuY3kgbWVkaWNpbmU8L3NlY29uZGFyeS10aXRs

ZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Bbm5hbHMgb2YgZW1lcmdlbmN5IG1l

ZGljaW5lPC9mdWxsLXRpdGxlPjxhYmJyLTE+QW5uIEVtZXJnIE1lZDwvYWJici0xPjwvcGVyaW9k

aWNhbD48cGFnZXM+NDYwLTQ3MTwvcGFnZXM+PHZvbHVtZT40NDwvdm9sdW1lPjxudW1iZXI+NTwv

bnVtYmVyPjxkYXRlcz48eWVhcj4yMDA0PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDE5Ni0wNjQ0PC9p

c2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4yMTI1NjYyNTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+MTAuMTAxNi9qLmFubmVtZXJnbWVkLjIwMDQuMDYuMDA2PC9lbGVjdHJvbmlj

LXJlc291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5TdHJheWVyPC9BdXRo

b3I+PFllYXI+MjAwODwvWWVhcj48UmVjTnVtPjM5PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJl

cj4zOTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncw

d3N2cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTQxNjEzODg2Ij4z

OTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3

PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJv

bGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPlN0cmF5ZXIsIFJldWJlbiBKPC9zdHlsZT48

L2F1dGhvcj48YXV0aG9yPk5lbHNvbiwgTGV3aXMgUzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRy

aWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5BZHZlcnNlIGV2ZW50cyBhc3NvY2lhdGVkIHdpdGgga2V0

YW1pbmUgZm9yIHByb2NlZHVyYWwgc2VkYXRpb24gaW4gYWR1bHRzPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPlRoZSBBbWVyaWNhbiBqb3VybmFsIG9mIGVtZXJnZW5jeSBtZWRpY2luZTwvc2Vjb25k

YXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPlRoZSBBbWVyaWNhbiBq

b3VybmFsIG9mIGVtZXJnZW5jeSBtZWRpY2luZTwvZnVsbC10aXRsZT48YWJici0xPkFtIEogRW1l

cmcgTWVkPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz45ODUtMTAyODwvcGFnZXM+PHZvbHVt

ZT4yNjwvdm9sdW1lPjxudW1iZXI+OTwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA4PC95ZWFyPjwv

ZGF0ZXM+PGlzYm4+MDczNS02NzU3PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xOTA5MTI2

NDwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTAxNi9qLmFqZW0uMjAwNy4x

Mi4wMDU8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+

ADDIN EN.CITE.DATA [8,9]. In our study, these features are important for sedation safety, since sedation is performed by non-anaesthesia personnel.It is claimed that the application of propofol without anaesthetist is dangerous. Even in the United States, the Food and Drug Administration recommends that the propofol should be performed only by trained anaesthesia personnelPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SZXg8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxSZWNO

dW0+MzM8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij5bMTAs

IDExXTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjMzPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZy

NnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQzNjM4NTQiPjMzPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVm

YXVsdCIgc2l6ZT0iMTAwJSI+UmV4LCBEb3VnbGFzIEs8L3N0eWxlPjwvYXV0aG9yPjwvYXV0aG9y

cz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5FZmZlY3Qgb2YgdGhlIENlbnRlcnMgZm9y

IE1lZGljYXJlICZhbXA7IE1lZGljYWlkIFNlcnZpY2VzIHBvbGljeSBhYm91dCBkZWVwIHNlZGF0

aW9uIG9uIHVzZSBvZiBwcm9wb2ZvbDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm5hbHMgb2Yg

aW50ZXJuYWwgbWVkaWNpbmU8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5Bbm5hbHMgb2YgaW50ZXJuYWwgbWVkaWNpbmU8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5Bbm4gSW50ZXJuIE1lZDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+NjIyLTYyNjwvcGFn

ZXM+PHZvbHVtZT4xNTQ8L3ZvbHVtZT48bnVtYmVyPjk8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAx

MTwveWVhcj48L2RhdGVzPjxpc2JuPjAwMDMtNDgxOTwvaXNibj48dXJscz48L3VybHM+PGN1c3Rv

bTI+MjE1MzY5Mzg8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjczMjYvMDAw

My00ODE5LTE1NC05LTIwMTEwNTAzMC0wMDAwNzwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9y

ZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QWlzZW5iZXJnPC9BdXRob3I+PFllYXI+MjAwNzwv

WWVhcj48UmVjTnVtPjM0PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zNDwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2

c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MzYzOTIxIj4zNDwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRlZmF1

bHQiIHNpemU9IjEwMCUiPkFpc2VuYmVyZywgSmFtZXM8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+

Q29oZW4sIExhd3JlbmNlIEI8L2F1dGhvcj48YXV0aG9yPlBpb3Jrb3dza2kgSnIsIEpvc2VwaCBE

PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlByb3BvZm9s

IHVzZSB1bmRlciB0aGUgZGlyZWN0aW9uIG9mIHRyYWluZWQgZ2FzdHJvZW50ZXJvbG9naXN0czog

YW4gYW5hbHlzaXMgb2YgdGhlIG1lZGljb2xlZ2FsIGltcGxpY2F0aW9uczwvdGl0bGU+PHNlY29u

ZGFyeS10aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0cm9lbnRlcm9sb2d5PC9zZWNv

bmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+VGhlIEFtZXJpY2Fu

IGpvdXJuYWwgb2YgZ2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkFtIEogR2Fz

dHJvZW50ZXJvbDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+PHN0eWxlIGZhY2U9Im5vcm1h

bCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+NzA3PC9zdHlsZT48c3R5bGUgZmFjZT0ibm9y

bWFsIiBmb250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEwMCUiPi03MTM8L3N0eWxl

PjwvcGFnZXM+PHZvbHVtZT4xMDI8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZGF0ZXM+PHll

YXI+MjAwNzwveWVhcj48L2RhdGVzPjxpc2JuPjE1NzItMDI0MTwvaXNibj48dXJscz48L3VybHM+

PGN1c3RvbTI+MTczOTc0MDI8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEx

MTEvai4xNTcyLTAyNDEuMjAwNi4wMDk1NS54PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5SZXg8L0F1dGhvcj48WWVhcj4yMDExPC9ZZWFyPjxSZWNO

dW0+MzM8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij5bMTAs

IDExXTwvc3R5bGU+PC9EaXNwbGF5VGV4dD48cmVjb3JkPjxyZWMtbnVtYmVyPjMzPC9yZWMtbnVt

YmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZy

NnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQzNjM4NTQiPjMzPC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVm

YXVsdCIgc2l6ZT0iMTAwJSI+UmV4LCBEb3VnbGFzIEs8L3N0eWxlPjwvYXV0aG9yPjwvYXV0aG9y

cz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5FZmZlY3Qgb2YgdGhlIENlbnRlcnMgZm9y

IE1lZGljYXJlICZhbXA7IE1lZGljYWlkIFNlcnZpY2VzIHBvbGljeSBhYm91dCBkZWVwIHNlZGF0

aW9uIG9uIHVzZSBvZiBwcm9wb2ZvbDwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Bbm5hbHMgb2Yg

aW50ZXJuYWwgbWVkaWNpbmU8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48

ZnVsbC10aXRsZT5Bbm5hbHMgb2YgaW50ZXJuYWwgbWVkaWNpbmU8L2Z1bGwtdGl0bGU+PGFiYnIt

MT5Bbm4gSW50ZXJuIE1lZDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+NjIyLTYyNjwvcGFn

ZXM+PHZvbHVtZT4xNTQ8L3ZvbHVtZT48bnVtYmVyPjk8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAx

MTwveWVhcj48L2RhdGVzPjxpc2JuPjAwMDMtNDgxOTwvaXNibj48dXJscz48L3VybHM+PGN1c3Rv

bTI+MjE1MzY5Mzg8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjczMjYvMDAw

My00ODE5LTE1NC05LTIwMTEwNTAzMC0wMDAwNzwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9y

ZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+QWlzZW5iZXJnPC9BdXRob3I+PFllYXI+MjAwNzwv

WWVhcj48UmVjTnVtPjM0PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4zNDwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2

c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MzYzOTIxIj4zNDwva2V5PjwvZm9yZWln

bi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29u

dHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRlZmF1

bHQiIHNpemU9IjEwMCUiPkFpc2VuYmVyZywgSmFtZXM8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+

Q29oZW4sIExhd3JlbmNlIEI8L2F1dGhvcj48YXV0aG9yPlBpb3Jrb3dza2kgSnIsIEpvc2VwaCBE

PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlByb3BvZm9s

IHVzZSB1bmRlciB0aGUgZGlyZWN0aW9uIG9mIHRyYWluZWQgZ2FzdHJvZW50ZXJvbG9naXN0czog

YW4gYW5hbHlzaXMgb2YgdGhlIG1lZGljb2xlZ2FsIGltcGxpY2F0aW9uczwvdGl0bGU+PHNlY29u

ZGFyeS10aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0cm9lbnRlcm9sb2d5PC9zZWNv

bmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+VGhlIEFtZXJpY2Fu

IGpvdXJuYWwgb2YgZ2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkFtIEogR2Fz

dHJvZW50ZXJvbDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+PHN0eWxlIGZhY2U9Im5vcm1h

bCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+NzA3PC9zdHlsZT48c3R5bGUgZmFjZT0ibm9y

bWFsIiBmb250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEwMCUiPi03MTM8L3N0eWxl

PjwvcGFnZXM+PHZvbHVtZT4xMDI8L3ZvbHVtZT48bnVtYmVyPjQ8L251bWJlcj48ZGF0ZXM+PHll

YXI+MjAwNzwveWVhcj48L2RhdGVzPjxpc2JuPjE1NzItMDI0MTwvaXNibj48dXJscz48L3VybHM+

PGN1c3RvbTI+MTczOTc0MDI8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEx

MTEvai4xNTcyLTAyNDEuMjAwNi4wMDk1NS54PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PC9FbmROb3RlPgB=

ADDIN EN.CITE.DATA [10,11]. However, a worldwide study has shown that no major complications occur in patients (less than 1% of 142863 patients) ADDIN EN.CITE <EndNote><Cite><Author>Lienhart</Author><Year>2002</Year><RecNum>18</RecNum><DisplayText><style face="superscript">[12]</style></DisplayText><record><rec-number>18</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068395">18</key></foreign-keys><ref-type name="Conference Proceedings">10</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Lienhart, A</style></author><author>Carli, P</author><author>Marty, J</author><author>Pourriat, JL</author></authors></contributors><titles><title>Digestive endoscopies: who does what?</title><secondary-title>Annales francaises d&apos;anesthesie et de reanimation</secondary-title></titles><pages>343-346</pages><volume>21</volume><number>5</number><dates><year>2002</year></dates><isbn>0750-7658</isbn><urls></urls></record></Cite></EndNote>[12]. Patient-controlled analgesia (PCA) pump was developed for postoperative pain control. In this regard, the patient applies his own pain medication according to the need himself. The PCA pump was then used with the same logic to provide sedation rather than analgesia in several studies. There are also studies where sedation applications have been performed under the supervision of a nurse or endoscopist using these pre-programmed devices ADDIN EN.CITE <EndNote><Cite><Author>Crepeau</Author><Year>2005</Year><RecNum>17</RecNum><DisplayText><style face="superscript">[13]</style></DisplayText><record><rec-number>17</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068389">17</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Crepeau, Thomas</style></author><author>Poincloux, Laurent</author><author>Bonny, Corinne</author><author>Lighetto, Sylvie</author><author>Jaffeux, Patricia</author><author>Artigue, Fabrice</author><author>Walleckx, Pierre</author><author>Bazin, Jean Etienne</author><author>Dapoigny, Michel</author><author>Bommelaer, Gilles</author></authors></contributors><titles><title>Significance of patient-controlled sedation during colonoscopy: Results from a prospective randomized controlled study</title><secondary-title>Gastroentérologie clinique et biologique</secondary-title></titles><periodical><full-title>Gastroentérologie clinique et biologique</full-title><abbr-1>Gastroenterol Clin Biol</abbr-1></periodical><pages>1090-1096</pages><volume>29</volume><number>11</number><dates><year>2005</year></dates><isbn>0399-8320</isbn><urls></urls><custom2>16505753</custom2><electronic-resource-num>10.1016/S0399-8320(05)82172-4</electronic-resource-num></record></Cite></EndNote>[13]. In this study, we aim to compare the application of midazolam-ketamine-propofol combination by endoscopy nurse with PCA pump and anaesthetist in terms of patient satisfaction and side effect (safety).MATERIALS AND METHODSAfter receiving the approval of the ethical committee of the Medical School of Erciyes University and the informed consent of the patients, the study included the American Statistical Association (ASA) I-II 60 patients who underwent the elective colonoscopy between 18 and 75 years of age. The study protocol was registered at (NCT03607110, ). ASA III-IV-V patients, who have uncontrolled chronic disease (uncontrolled diabetes mellitus and hypertension), severe respiratory and cardiopulmonary insufficiency or liver, and kidney failure who did not accept the method were not included in the study. Patients with long-term analgesic, opioid, and sedative history of use, with hypersensitivity to soybean oil or eggs, and drugs used in our study, with pregnancy or pregnancy suspected or lactating, and with the use of antipsychotic or antidepressant drugs were also excluded in the examination.Before the procedure, the group in which the patients would be included was randomly determined by the endoscopy nurse. The patients were given a proper diet before the procedure and the intestinal cleansing was -implemented. After 8 h of fasting, the peripheral vascular route was opened with a 20G cannula and 8 mL kg/h crystalloid solution was performed. Prior to sedation, all patients were monitored for heart rate, mean arterial pressure, and peripheral oxygen saturation (SpO2) measurements. All patients were given 5 lt/min oxygen with nasal cannula. Colonoscopy; was performed by two experienced endoscopists who were trained in the same center on the same dates.During the procedure, the monitored data and the cardiopulmonary side effects were recorded once in a minute for the first 5-min period and once in every 5 min in the next period. In the SSA group, the anaesthetist was at the bedside of the patient. A total of two nurses, one was trained for sedation and the other of whom would assist the endoscopist during the colonoscopy, were presented in the supervision of endoscopy nurse (SSEN) group. The nurse trained for sedation was informed about possible side effects such as desaturation (< 90%), hypotension (systolic < 90 mm-Hg), and bradycardia (< 50) during the procedure and was also trained to perform the necessary interventions (such as jaw-thrust and head tilt chin lift manoeuvres or using oropharyngeal airway in case of desaturation or atropine administration in case of bradycardia or 250 cc of fluid loading in case of hypotension). If hypotension is continued, 5-10 mg IV ephedrine will be administered. In cases where peripheral oxygen saturation don’t increase or continue to decline (below 85) the anaesthetist will intervene. In the case of long-term desaturation, the materials required for emergency airway management (bag mask ventilation, intubation, etc.) will be available in the endoscopy room to provide respiratory support. The anaesthetist was not at the bedside of the patient in the group SSA. However, the anaesthetist was ready in the endoscopy unit for intervention in emergency situations such as intubation and cardiopulmonary resuscitation.Sedation protocol: Both groups were initially administered 1 mg of midazolam, 50 mg of ketamine, and 30-50 mg of propofol (30 mg in patients over 65 years old and 50 mg in patients under 65 years old). Afterwards, the propofol required for the SSA group was determined and administered by the anaesthetist to provide adequate sedation and patient comfort. For SSEN group, the continuation of sedation was performed by endoscopy nurse using PCA pump (Accumate 1100; Woo Young Medical, Seoul, Korea). Each time the endoscopy nurse pressed the PCA pump according to the patient’s clinical response or tolerance, the patient was administered propofol 10-20 mg (10 mg in patients over 65 years old, 20 mg in patients under 65 years) with a delay of about 10-20 s. At the end of the procedure, the total drug consumption, the duration of the procedure, and the patients’ eye opening/recovery times were recorded.Patient Satisfaction: Patients were monitored until the Aldrete Recovery Score (ARS) was ≥ 9. Patients with the ARS ≥ 9 were transferred to another eligible unit. In order to evaluate patient satisfaction, the patients were asked of questions about the procedure in this unit. A visual analogue scale (VAS) was used to evaluate the pain after the procedure. Patients were asked to rate their pain on a scale of 0-10. Zero (0) would mean “no pain” and ten (10) would mean “worst imaginable pain”.Patients were also questioned about whether they remembered the operation and side effects. Side effects such as hypotension, bradycardia and desaturation, which require serious and rapid intervention, and frequently encountered side effects such as nausea, vomiting, and headache, which may adversely affect patient satisfaction, included in the patient follow-up form as main substances. Apart from these side effects, endoscopy nurse was especially informed about complications related to ketamine such as emergence reactions, hypertension, tachycardia, visual hallucinations, vivid dreams, tonic-clonic movements, diplopia, and nystagmus. However, in the patient follow-up form, these side effects were not mentioned separately, were included under the title of other side effects. In addition, patient satisfaction was determined by satisfaction score of 4 (1 very good, 2 good, 3 not bad, 4 bad). Two days after the procedure, the patients were asked whether they would re-prefer for the same method in case of re-endoscopy and their answers were recorded. Patients were questioned for possible delayed side effects when they were contacted 2 d after the colonoscopy to determine method preference.Statistical methodMean SD, median lowest, highest, frequency, and ratio values were used in the descriptive statistics of the data. The distribution of the variables was measured by the Kolmogorov Smirnov test. Mann-Whitney U test was utilized in the analysis of quantitative independent data. Chi-square test was -employed to analyse qualitative independent data, and Fischer test was used when chi-square test conditions were not met. In all analyses, the P-value < 0.05 was considered as statistically significant. SPSS 22.0 program was used in the analyses.RESULTSThere was no significant difference (P > 0.05) between SSA group and SSEN group in terms of demographic data such as age, gender distribution, and ASA distribution. Patients’ demographic data is given in Table 1.The total propofol used in the SSEN group was found to be significantly higher (P < 0.05) than the SSA group. Reaching the cecum and total procedure time in the SSEN group were found to be significantly higher (P < 0.05) than in the SSA group (Table 2).When patients were asked about their satisfaction, 1 patient in the SSEN group and 5 patients in the SSA group expressed their satisfaction as “not bad”, the rest of patients expressed their satisfaction with “good” or “very good”. In each groups, 3 patients said that they remembered the procedure. All patients in both groups except 2 patients in the SSA group stated that they would re-prefer the same method for the second time. However, when the groups were compared in terms of patient satisfaction, recall of the procedure, and re-preferring the same method in case of re-endoscopy, there was no significant difference (P > 0.05) between the two groups (Table 2).Patients’ pain was evaluated by VAS score after the procedure. The highest recorded VAS value is 4. In each groups, only one patient had a VAS score of 4. The mean value of the VAS score is 1 in each group. Recovery times are also similar between the two groups. There was no statistically significant difference (P > 0.05) between the two groups in terms of VAS score and recovery time.Two groups were also compared in terms of hemodynamic parameters recorded during the procedure. Pulse values taken at the baseline, 1st minute, 2nd minute, 3rd minute, 4th minute, 5th minute, 8th minute, and afterwards did not differ significantly between the two groups (P > 0.05). While the systolic and diastolic pressure values of the SSA and SSEN groups did not differ significantly (P > 0.05) at the baseline, 1st minute, 2nd minute, 3rd minute, and 4th minute, Systolic and diastolic pressure values were found to be significantly lower (P < 0.05) in the SSEN group than in the SSA group in the 5th minute, 8th minute, and afterwards. SPO2 values for the baseline and 1st minute in the SSEN group were found to be significantly higher (P < 0.05) than in the SSA group, There was no significant (P > 0.05) difference in SPO2 values for 2nd minute, 3rd minute, 4th minute, 8th minutes and afterwards between the two groups (Table 3).The groups were also compared in terms of the side effects that might occur during the procedure. In each groups, hypotension and headache occurred in 2 patients. Bradycardia was observed in only 1 patient in the SSEN group. When the groups were compared in terms of desaturation, 4 patients in the SSEN group and 1 patient in the SSA group had desaturation. Nausea and vomiting were not seen in either group. However, there was no statistically significant difference (P > 0.05) between the two groups (Table 4).DISCUSSIONIn the majority of developed countries, various sedation applications are made for endoscopic procedures in low-risk patients. When we examine the agents used for analgesia and sedation in endoscopic procedures over time; meperidine was first used as an analgesic, followed by extensive use of the meperidine diazepam combination. This combination, which is often preferred, is accepted as a traditional sedation method. Later, midazolam was preferred in endoscopy sedation with shorter duration of action and higher efficacy than diazepam. A few years after midazolam, propofol, an ultra-short acting hypnotic agent, started to be used ADDIN EN.CITE <EndNote><Cite><Author>Ferreira</Author><Year>2015</Year><RecNum>24</RecNum><DisplayText><style face="superscript">[2]</style></DisplayText><record><rec-number>24</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068429">24</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Ferreira, Alexandre Oliveira</style></author><author>Cravo, Marília</author></authors></contributors><titles><title>Sedation in gastrointestinal endoscopy: Where are we at in 2014?</title><secondary-title>World journal of gastrointestinal endoscopy</secondary-title></titles><periodical><full-title>World journal of gastrointestinal endoscopy</full-title><abbr-1>World J Gastrointest Endosc</abbr-1></periodical><pages><style face="normal" font="default" size="100%">102</style><style face="normal" font="default" charset="162" size="100%">-109</style></pages><volume>7</volume><number>2</number><dates><year>2015</year></dates><urls></urls><custom2>25685266</custom2><electronic-resource-num>10.4253/wjge.v7.i2.102</electronic-resource-num></record></Cite></EndNote>[2].Propofol sedation is becoming more popular day by day due to its features such as pain relief during endoscopy and the ability to have a quick recovery time ADDIN EN.CITE <EndNote><Cite><Author>Lin</Author><Year>2017</Year><RecNum>23</RecNum><DisplayText><style face="superscript">[3]</style></DisplayText><record><rec-number>23</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068424">23</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Lin, Otto S</style></author></authors></contributors><titles><title>Sedation for routine gastrointestinal endoscopic procedures: a review on efficacy, safety, efficiency, cost and satisfaction</title><secondary-title>Intestinal research</secondary-title></titles><periodical><full-title>Intestinal research</full-title><abbr-1>Intest Res</abbr-1></periodical><pages>456-466</pages><volume>15</volume><number>4</number><dates><year>2017</year></dates><isbn>1598-9100</isbn><urls></urls><custom2>29142513</custom2><electronic-resource-num>10.5217/ir.2017.15.4.456</electronic-resource-num></record></Cite></EndNote>[3]. However, it is controversial whether the propofol should be applied by anaesthesia personnel or educated non-anaesthesia personnel. In European and American guidelines, it is stated that sedation applied by non-anaesthesia personnel should be applied only in low-risk patients and that sedation personnel should be qualified to rescue patients from any level of sedation including general anaesthesia ADDIN EN.CITE <EndNote><Cite><Author>Gross</Author><Year>2002</Year><RecNum>27</RecNum><DisplayText><style face="superscript">[14]</style></DisplayText><record><rec-number>27</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534137192">27</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Jeffrey B Gross</style></author><author><style face="normal" font="default" charset="162" size="100%">F</style><style face="normal" font="default" size="100%">armington, CT</style></author><author> Peter L. Bailey</author><author>Richard T. Connis</author><author>Charles J. Cote</author><author>Fred G. Davis</author><author>Burton S. Epstein</author><author>Lesley Gilbertson</author><author>David G. Nickinovich</author><author>John M. Zerwas</author><author>Gregory Zuccaro</author></authors></contributors><titles><title>Practice guidelines for sedation and analgesia by non-anesthesiologists</title><secondary-title>Anesthesiology</secondary-title></titles><periodical><full-title>Anesthesiology</full-title><abbr-1>Anesthesiology</abbr-1></periodical><pages><style face="normal" font="default" size="100%">1004-</style><style face="normal" font="default" charset="162" size="100%">10</style><style face="normal" font="default" size="100%">17</style></pages><volume>96</volume><number>4</number><dates><year>2002</year></dates><urls></urls><custom2>11964611</custom2></record></Cite></EndNote>[14]. However, in various studies it has been shown that sedation performed by non-anaesthesia personnel can be safely performed as long as it is performed by educated personnelPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWVnPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48UmVj

TnVtPjU8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij5bMTUt

MThdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2

c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4MjczIj41PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVmYXVs

dCIgc2l6ZT0iMTAwJSI+U2llZywgQW5kcmVhczwvc3R5bGU+PC9hdXRob3I+PGF1dGhvcj48c3R5

bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5ibmc8L3N0eWxlPjxz

dHlsZSBmYWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIGNoYXJzZXQ9IjE2MiIgc2l6ZT0iMTAw

JSI+LTwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAw

JSI+U3R1ZHk8L3N0eWxlPjxzdHlsZSBmYWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIGNoYXJz

ZXQ9IjE2MiIgc2l6ZT0iMTAwJSI+LTwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0i

ZGVmYXVsdCIgc2l6ZT0iMTAwJSI+R3JvdXA8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+QmVjaywg

U2ViYXN0aWFuPC9hdXRob3I+PGF1dGhvcj5TY2hvbGwsIFNhYmluZSBHPC9hdXRob3I+PGF1dGhv

cj5IZWlsLCBGcmFueiBKPC9hdXRob3I+PGF1dGhvcj5Hb3R0aGFyZHQsIERhbmllbCBOPC9hdXRo

b3I+PGF1dGhvcj5TdHJlbW1lbCwgV29sZmdhbmc8L2F1dGhvcj48YXV0aG9yPlJleCwgRG91Z2xh

cyBLPC9hdXRob3I+PGF1dGhvcj5GcmllZHJpY2gsIEtpbGlhbjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5TYWZldHkgYW5hbHlzaXMgb2YgZW5kb3Njb3Bpc3Q8L3N0eWxl

PjxzdHlsZSBmYWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIGNoYXJzZXQ9IjE2MiIgc2l6ZT0i

MTAwJSI+LTwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0i

MTAwJSI+ZGlyZWN0ZWQgcHJvcG9mb2wgc2VkYXRpb246IEEgcHJvc3BlY3RpdmUsIG5hdGlvbmFs

IG11bHRpY2VudGVyIHN0dWR5IG9mIDI0IDQ0MSBwYXRpZW50cyBpbiBHZXJtYW4gb3V0cGF0aWVu

dCBwcmFjdGljZXM8L3N0eWxlPjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Kb3VybmFsIG9mIGdh

c3Ryb2VudGVyb2xvZ3kgYW5kIGhlcGF0b2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIGdhc3Ryb2VudGVyb2xvZ3kgYW5kIGhl

cGF0b2xvZ3k8L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEdhc3Ryb2VudGVyb2wgSGVwYXRvbDwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48cGFnZXM+NTE3LTUyMzwvcGFnZXM+PHZvbHVtZT4yOTwvdm9sdW1l

PjxudW1iZXI+MzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjwvZGF0ZXM+PGlzYm4+

MDgxNS05MzE5PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4yNDcxNjIxMzwvY3VzdG9tMj48

ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTExMS9qZ2guMTI0NTg8L2VsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJleDwvQXV0aG9yPjxZZWFy

PjIwMDk8L1llYXI+PFJlY051bT44PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj44PC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFl

YXZyNnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgyOTIiPjg8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5SZXgsIERvdWdsYXMgSzwvc3R5bGU+PC9hdXRob3I+PGF1dGhv

cj5EZWVuYWRheWFsdSwgVmlqdSBQPC9hdXRob3I+PGF1dGhvcj5FaWQsIEVtZWx5PC9hdXRob3I+

PGF1dGhvcj5JbXBlcmlhbGUsIFRob21hcyBGPC9hdXRob3I+PGF1dGhvcj5XYWxrZXIsIEpvaG4g

QTwvYXV0aG9yPjxhdXRob3I+U2FuZGh1LCBLdWxkaXA8L2F1dGhvcj48YXV0aG9yPkNsYXJrZSwg

QW50aG9ueSBDPC9hdXRob3I+PGF1dGhvcj5IaWxsbWFuLCBMeWJ1cyBDPC9hdXRob3I+PGF1dGhv

cj5Ib3JpdWNoaSwgQWtpcmE8L2F1dGhvcj48YXV0aG9yPkNvaGVuLCBMYXdyZW5jZSBCPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkVuZG9zY29waXN0LWRp

cmVjdGVkIGFkbWluaXN0cmF0aW9uIG9mIHByb3BvZm9sOiBhIHdvcmxkd2lkZSBzYWZldHkgZXhw

ZXJpZW5jZTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5HYXN0cm9lbnRlcm9sb2d5PC9zZWNvbmRh

cnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+R2FzdHJvZW50ZXJvbG9n

eTwvZnVsbC10aXRsZT48YWJici0xPkdhc3Ryb2VudGVyb2xvZ3k8L2FiYnItMT48L3BlcmlvZGlj

YWw+PHBhZ2VzPjEyMjktMTIzNzwvcGFnZXM+PHZvbHVtZT4xMzc8L3ZvbHVtZT48bnVtYmVyPjQ8

L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48L2RhdGVzPjxpc2JuPjAwMTYtNTA4NTwv

aXNibj48dXJscz48L3VybHM+PGN1c3RvbTI+MTk1NDk1Mjg8L2N1c3RvbTI+PGVsZWN0cm9uaWMt

cmVzb3VyY2UtbnVtPjEwLjEwNTMvai5nYXN0cm8uMjAwOS4wNi4wNDI8L2VsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJleDwvQXV0aG9yPjxZZWFy

PjIwMDU8L1llYXI+PFJlY051bT42PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj42PC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFl

YXZyNnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgyODAiPjY8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5SZXgsIERvdWdsYXMgSzwvc3R5bGU+PC9hdXRob3I+PGF1dGhv

cj5IZXVzcywgTHVkd2lnIFQ8L2F1dGhvcj48YXV0aG9yPldhbGtlciwgSm9obiBBPC9hdXRob3I+

PGF1dGhvcj5RaSwgUm9uZzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVz

Pjx0aXRsZT5UcmFpbmVkIHJlZ2lzdGVyZWQgbnVyc2VzL2VuZG9zY29weSB0ZWFtcyBjYW4gYWRt

aW5pc3RlciBwcm9wb2ZvbCBzYWZlbHkgZm9yIGVuZG9zY29weTwvdGl0bGU+PHNlY29uZGFyeS10

aXRsZT5HYXN0cm9lbnRlcm9sb2d5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+R2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkdhc3Ry

b2VudGVyb2xvZ3k8L2FiYnItMT48L3BlcmlvZGljYWw+PHBhZ2VzPjEzODQtMTM5MTwvcGFnZXM+

PHZvbHVtZT4xMjk8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNTwv

eWVhcj48L2RhdGVzPjxpc2JuPjAwMTYtNTA4NTwvaXNibj48dXJscz48L3VybHM+PGN1c3RvbTI+

MTYyODU5Mzk8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwNTMvai5nYXN0

cm8uMjAwNS4wOC4wMTQ8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48

Q2l0ZT48QXV0aG9yPlNhdGhhbmFudGhhbjwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+PFJlY051

bT43PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj43PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZyNnZzeDkyZXQyNTV4NTJw

NTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgyODYiPjc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5

cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0

aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAl

Ij5TYXRoYW5hbnRoYW4sIERoYXJzaGFuPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPllvdW5nLCBF

ZHdhcmQ8L2F1dGhvcj48YXV0aG9yPk5pbmQsIEdhcnJ5PC9hdXRob3I+PGF1dGhvcj5HZW9yZ2Us

IEJpanU8L2F1dGhvcj48YXV0aG9yPkFzaGJ5LCBBbmdlbGllPC9hdXRob3I+PGF1dGhvcj5EcnVt

bW9uZCwgU2hhcm9uPC9hdXRob3I+PGF1dGhvcj5SZWRlbCwgS2FzaWE8L2F1dGhvcj48YXV0aG9y

PkdyZWVuLCBOZXZpbGxlPC9hdXRob3I+PGF1dGhvcj5TaW5naCwgUmFqdmluZGVyPC9hdXRob3I+

PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkFzc2Vzc2luZyB0aGUgc2Fm

ZXR5IG9mIHBoeXNpY2lhbi1kaXJlY3RlZCBudXJzZS1hZG1pbmlzdGVyZWQgcHJvcG9mb2wgc2Vk

YXRpb24gaW4gbG93LXJpc2sgcGF0aWVudHMgdW5kZXJnb2luZyBlbmRvc2NvcHkgYW5kIGNvbG9u

b3Njb3B5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVuZG9zY29weSBpbnRlcm5hdGlvbmFsIG9w

ZW48L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FbmRv

c2NvcHkgaW50ZXJuYXRpb25hbCBvcGVuPC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3NjIEludCBP

cGVuPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250

PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5FMTEwPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBm

b250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEwMCUiPi08L3N0eWxlPjxzdHlsZSBm

YWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPkUxMTwvc3R5bGU+PHN0eWxl

IGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBzaXplPSIxMDAlIj41

PC9zdHlsZT48L3BhZ2VzPjx2b2x1bWU+NTwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxkYXRl

cz48eWVhcj4yMDE3PC95ZWFyPjwvZGF0ZXM+PHVybHM+PC91cmxzPjxjdXN0b20yPjI4MjEwNzA3

PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDU1L3MtMDA0Mi0xMjE2Njc8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWVnPC9BdXRob3I+PFllYXI+MjAxNDwvWWVhcj48UmVj

TnVtPjU8L1JlY051bT48RGlzcGxheVRleHQ+PHN0eWxlIGZhY2U9InN1cGVyc2NyaXB0Ij5bMTUt

MThdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+NTwvcmVjLW51bWJl

cj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2

c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4MjczIj41PC9rZXk+PC9mb3JlaWdu

LWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250

cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVmYXVs

dCIgc2l6ZT0iMTAwJSI+U2llZywgQW5kcmVhczwvc3R5bGU+PC9hdXRob3I+PGF1dGhvcj48c3R5

bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5ibmc8L3N0eWxlPjxz

dHlsZSBmYWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIGNoYXJzZXQ9IjE2MiIgc2l6ZT0iMTAw

JSI+LTwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAw

JSI+U3R1ZHk8L3N0eWxlPjxzdHlsZSBmYWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIGNoYXJz

ZXQ9IjE2MiIgc2l6ZT0iMTAwJSI+LTwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0i

ZGVmYXVsdCIgc2l6ZT0iMTAwJSI+R3JvdXA8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+QmVjaywg

U2ViYXN0aWFuPC9hdXRob3I+PGF1dGhvcj5TY2hvbGwsIFNhYmluZSBHPC9hdXRob3I+PGF1dGhv

cj5IZWlsLCBGcmFueiBKPC9hdXRob3I+PGF1dGhvcj5Hb3R0aGFyZHQsIERhbmllbCBOPC9hdXRo

b3I+PGF1dGhvcj5TdHJlbW1lbCwgV29sZmdhbmc8L2F1dGhvcj48YXV0aG9yPlJleCwgRG91Z2xh

cyBLPC9hdXRob3I+PGF1dGhvcj5GcmllZHJpY2gsIEtpbGlhbjwvYXV0aG9yPjwvYXV0aG9ycz48

L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5TYWZldHkgYW5hbHlzaXMgb2YgZW5kb3Njb3Bpc3Q8L3N0eWxl

PjxzdHlsZSBmYWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIGNoYXJzZXQ9IjE2MiIgc2l6ZT0i

MTAwJSI+LTwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0i

MTAwJSI+ZGlyZWN0ZWQgcHJvcG9mb2wgc2VkYXRpb246IEEgcHJvc3BlY3RpdmUsIG5hdGlvbmFs

IG11bHRpY2VudGVyIHN0dWR5IG9mIDI0IDQ0MSBwYXRpZW50cyBpbiBHZXJtYW4gb3V0cGF0aWVu

dCBwcmFjdGljZXM8L3N0eWxlPjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5Kb3VybmFsIG9mIGdh

c3Ryb2VudGVyb2xvZ3kgYW5kIGhlcGF0b2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5Kb3VybmFsIG9mIGdhc3Ryb2VudGVyb2xvZ3kgYW5kIGhl

cGF0b2xvZ3k8L2Z1bGwtdGl0bGU+PGFiYnItMT5KIEdhc3Ryb2VudGVyb2wgSGVwYXRvbDwvYWJi

ci0xPjwvcGVyaW9kaWNhbD48cGFnZXM+NTE3LTUyMzwvcGFnZXM+PHZvbHVtZT4yOTwvdm9sdW1l

PjxudW1iZXI+MzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjwvZGF0ZXM+PGlzYm4+

MDgxNS05MzE5PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4yNDcxNjIxMzwvY3VzdG9tMj48

ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTExMS9qZ2guMTI0NTg8L2VsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJleDwvQXV0aG9yPjxZZWFy

PjIwMDk8L1llYXI+PFJlY051bT44PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj44PC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFl

YXZyNnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgyOTIiPjg8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5SZXgsIERvdWdsYXMgSzwvc3R5bGU+PC9hdXRob3I+PGF1dGhv

cj5EZWVuYWRheWFsdSwgVmlqdSBQPC9hdXRob3I+PGF1dGhvcj5FaWQsIEVtZWx5PC9hdXRob3I+

PGF1dGhvcj5JbXBlcmlhbGUsIFRob21hcyBGPC9hdXRob3I+PGF1dGhvcj5XYWxrZXIsIEpvaG4g

QTwvYXV0aG9yPjxhdXRob3I+U2FuZGh1LCBLdWxkaXA8L2F1dGhvcj48YXV0aG9yPkNsYXJrZSwg

QW50aG9ueSBDPC9hdXRob3I+PGF1dGhvcj5IaWxsbWFuLCBMeWJ1cyBDPC9hdXRob3I+PGF1dGhv

cj5Ib3JpdWNoaSwgQWtpcmE8L2F1dGhvcj48YXV0aG9yPkNvaGVuLCBMYXdyZW5jZSBCPC9hdXRo

b3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkVuZG9zY29waXN0LWRp

cmVjdGVkIGFkbWluaXN0cmF0aW9uIG9mIHByb3BvZm9sOiBhIHdvcmxkd2lkZSBzYWZldHkgZXhw

ZXJpZW5jZTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5HYXN0cm9lbnRlcm9sb2d5PC9zZWNvbmRh

cnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+R2FzdHJvZW50ZXJvbG9n

eTwvZnVsbC10aXRsZT48YWJici0xPkdhc3Ryb2VudGVyb2xvZ3k8L2FiYnItMT48L3BlcmlvZGlj

YWw+PHBhZ2VzPjEyMjktMTIzNzwvcGFnZXM+PHZvbHVtZT4xMzc8L3ZvbHVtZT48bnVtYmVyPjQ8

L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwOTwveWVhcj48L2RhdGVzPjxpc2JuPjAwMTYtNTA4NTwv

aXNibj48dXJscz48L3VybHM+PGN1c3RvbTI+MTk1NDk1Mjg8L2N1c3RvbTI+PGVsZWN0cm9uaWMt

cmVzb3VyY2UtbnVtPjEwLjEwNTMvai5nYXN0cm8uMjAwOS4wNi4wNDI8L2VsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPlJleDwvQXV0aG9yPjxZZWFy

PjIwMDU8L1llYXI+PFJlY051bT42PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj42PC9yZWMt

bnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFl

YXZyNnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgyODAiPjY8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5SZXgsIERvdWdsYXMgSzwvc3R5bGU+PC9hdXRob3I+PGF1dGhv

cj5IZXVzcywgTHVkd2lnIFQ8L2F1dGhvcj48YXV0aG9yPldhbGtlciwgSm9obiBBPC9hdXRob3I+

PGF1dGhvcj5RaSwgUm9uZzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVz

Pjx0aXRsZT5UcmFpbmVkIHJlZ2lzdGVyZWQgbnVyc2VzL2VuZG9zY29weSB0ZWFtcyBjYW4gYWRt

aW5pc3RlciBwcm9wb2ZvbCBzYWZlbHkgZm9yIGVuZG9zY29weTwvdGl0bGU+PHNlY29uZGFyeS10

aXRsZT5HYXN0cm9lbnRlcm9sb2d5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGlj

YWw+PGZ1bGwtdGl0bGU+R2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRsZT48YWJici0xPkdhc3Ry

b2VudGVyb2xvZ3k8L2FiYnItMT48L3BlcmlvZGljYWw+PHBhZ2VzPjEzODQtMTM5MTwvcGFnZXM+

PHZvbHVtZT4xMjk8L3ZvbHVtZT48bnVtYmVyPjU8L251bWJlcj48ZGF0ZXM+PHllYXI+MjAwNTwv

eWVhcj48L2RhdGVzPjxpc2JuPjAwMTYtNTA4NTwvaXNibj48dXJscz48L3VybHM+PGN1c3RvbTI+

MTYyODU5Mzk8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEwLjEwNTMvai5nYXN0

cm8uMjAwNS4wOC4wMTQ8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48

Q2l0ZT48QXV0aG9yPlNhdGhhbmFudGhhbjwvQXV0aG9yPjxZZWFyPjIwMTc8L1llYXI+PFJlY051

bT43PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj43PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtl

eXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZyNnZzeDkyZXQyNTV4NTJw

NTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgyODYiPjc8L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5

cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0

aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAl

Ij5TYXRoYW5hbnRoYW4sIERoYXJzaGFuPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPllvdW5nLCBF

ZHdhcmQ8L2F1dGhvcj48YXV0aG9yPk5pbmQsIEdhcnJ5PC9hdXRob3I+PGF1dGhvcj5HZW9yZ2Us

IEJpanU8L2F1dGhvcj48YXV0aG9yPkFzaGJ5LCBBbmdlbGllPC9hdXRob3I+PGF1dGhvcj5EcnVt

bW9uZCwgU2hhcm9uPC9hdXRob3I+PGF1dGhvcj5SZWRlbCwgS2FzaWE8L2F1dGhvcj48YXV0aG9y

PkdyZWVuLCBOZXZpbGxlPC9hdXRob3I+PGF1dGhvcj5TaW5naCwgUmFqdmluZGVyPC9hdXRob3I+

PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPkFzc2Vzc2luZyB0aGUgc2Fm

ZXR5IG9mIHBoeXNpY2lhbi1kaXJlY3RlZCBudXJzZS1hZG1pbmlzdGVyZWQgcHJvcG9mb2wgc2Vk

YXRpb24gaW4gbG93LXJpc2sgcGF0aWVudHMgdW5kZXJnb2luZyBlbmRvc2NvcHkgYW5kIGNvbG9u

b3Njb3B5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVuZG9zY29weSBpbnRlcm5hdGlvbmFsIG9w

ZW48L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5FbmRv

c2NvcHkgaW50ZXJuYXRpb25hbCBvcGVuPC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3NjIEludCBP

cGVuPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250

PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5FMTEwPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBm

b250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEwMCUiPi08L3N0eWxlPjxzdHlsZSBm

YWNlPSJub3JtYWwiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPkUxMTwvc3R5bGU+PHN0eWxl

IGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBzaXplPSIxMDAlIj41

PC9zdHlsZT48L3BhZ2VzPjx2b2x1bWU+NTwvdm9sdW1lPjxudW1iZXI+MjwvbnVtYmVyPjxkYXRl

cz48eWVhcj4yMDE3PC95ZWFyPjwvZGF0ZXM+PHVybHM+PC91cmxzPjxjdXN0b20yPjI4MjEwNzA3

PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDU1L3MtMDA0Mi0xMjE2Njc8

L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA [15-18]. Walker et al ADDIN EN.CITE <EndNote><Cite><Author>Walker</Author><Year>2003</Year><RecNum>10</RecNum><DisplayText><style face="superscript">[19]</style></DisplayText><record><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068304">10</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Walker, John A</style></author><author>McIntyre, Robert D</author><author>Schleinitz, Paul F</author><author>Jacobson, Kris N</author><author>Haulk, Anthony A</author><author>Adesman, Peter</author><author>Tolleson, Shelley</author><author>Parent, Robyn</author><author>Donnelly, Rosie</author><author>Rex, Douglas K</author></authors></contributors><titles><title>Nurse-administered propofol sedation without anesthesia specialists in 9152 endoscopic cases in an ambulatory surgery center</title><secondary-title>The American journal of gastroenterology</secondary-title></titles><periodical><full-title>The American journal of gastroenterology</full-title><abbr-1>Am J Gastroenterol</abbr-1></periodical><pages>1744-1750</pages><volume>98</volume><number>8</number><dates><year>2003</year></dates><isbn>0002-9270</isbn><urls></urls><custom2>12907328</custom2><electronic-resource-num>10.1111/j.1572-0241.2003.07605.x</electronic-resource-num></record></Cite></EndNote>[19] showed that sedation performed by non-anaesthesia personnel in colonoscopy can be applied more easily and with lower risk than esophagogastroduodenoscopy. In a study/review by Rex et al ADDIN EN.CITE <EndNote><Cite><Author>Rex</Author><Year>2009</Year><RecNum>8</RecNum><DisplayText><style face="superscript">[16]</style></DisplayText><record><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068292">8</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Rex, Douglas K</style></author><author>Deenadayalu, Viju P</author><author>Eid, Emely</author><author>Imperiale, Thomas F</author><author>Walker, John A</author><author>Sandhu, Kuldip</author><author>Clarke, Anthony C</author><author>Hillman, Lybus C</author><author>Horiuchi, Akira</author><author>Cohen, Lawrence B</author></authors></contributors><titles><title>Endoscopist-directed administration of propofol: a worldwide safety experience</title><secondary-title>Gastroenterology</secondary-title></titles><periodical><full-title>Gastroenterology</full-title><abbr-1>Gastroenterology</abbr-1></periodical><pages>1229-1237</pages><volume>137</volume><number>4</number><dates><year>2009</year></dates><isbn>0016-5085</isbn><urls></urls><custom2>19549528</custom2><electronic-resource-num>10.1053/j.gastro.2009.06.042</electronic-resource-num></record></Cite></EndNote>[16], records of sedation applications performed by non-anaesthesia personnel from various centers around the world have been reviewed and evaluated. In this review/study involving 646080 patients, only 11 cases of emergency endotracheal intubation and 4 deaths were reported.In guidelines for propofol administration of non-anaesthesia personnel, it has been stated that ASA III and over patient procedures, long complex procedures, and difficult airway conditions require an anaesthetic personnelPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Hcm9zczwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+PFJl

Y051bT4yNzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPlsx

NCwgMjBdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+Mjc8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4YWVh

dnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDEzNzE5MiI+Mjc8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5KZWZmcmV5IEIgR3Jvc3M8L3N0eWxlPjwvYXV0aG9yPjxhdXRo

b3I+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBzaXpl

PSIxMDAlIj5GPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXpl

PSIxMDAlIj5hcm1pbmd0b24sIENUPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPiBQZXRlciBMLiBC

YWlsZXk8L2F1dGhvcj48YXV0aG9yPlJpY2hhcmQgVC4gQ29ubmlzPC9hdXRob3I+PGF1dGhvcj5D

aGFybGVzIEouIENvdGU8L2F1dGhvcj48YXV0aG9yPkZyZWQgRy4gRGF2aXM8L2F1dGhvcj48YXV0

aG9yPkJ1cnRvbiBTLiBFcHN0ZWluPC9hdXRob3I+PGF1dGhvcj5MZXNsZXkgR2lsYmVydHNvbjwv

YXV0aG9yPjxhdXRob3I+RGF2aWQgRy4gTmlja2lub3ZpY2g8L2F1dGhvcj48YXV0aG9yPkpvaG4g

TS4gWmVyd2FzPC9hdXRob3I+PGF1dGhvcj5HcmVnb3J5IFp1Y2Nhcm88L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+UHJhY3RpY2UgZ3VpZGVsaW5lcyBmb3Ig

c2VkYXRpb24gYW5kIGFuYWxnZXNpYSBieSBub24tYW5lc3RoZXNpb2xvZ2lzdHM8L3RpdGxlPjxz

ZWNvbmRhcnktdGl0bGU+QW5lc3RoZXNpb2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbmVzdGhlc2lvbG9neTwvZnVsbC10aXRsZT48YWJici0x

PkFuZXN0aGVzaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz48c3R5bGUgZmFjZT0i

bm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj4xMDA0LTwvc3R5bGU+PHN0eWxlIGZh

Y2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBzaXplPSIxMDAlIj4xMDwv

c3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+MTc8

L3N0eWxlPjwvcGFnZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxkYXRl

cz48eWVhcj4yMDAyPC95ZWFyPjwvZGF0ZXM+PHVybHM+PC91cmxzPjxjdXN0b20yPjExOTY0NjEx

PC9jdXN0b20yPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkR1bW9uY2VhdTwvQXV0aG9y

PjxZZWFyPjIwMTM8L1llYXI+PFJlY051bT4zNzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+

Mzc8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdz

dnBlNWR4YWVhdnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTU0MTU3MzU4OCI+Mzc8

L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwv

cmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xk

IiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5EdW1vbmNlYXUsIEotTTwvc3R5bGU+PC9hdXRo

b3I+PGF1dGhvcj5SaXBoYXVzLCBBPC9hdXRob3I+PGF1dGhvcj5CZWlsZW5ob2ZmLCBVPC9hdXRo

b3I+PGF1dGhvcj5WaWxtYW5uLCBQPC9hdXRob3I+PGF1dGhvcj5Ib3Juc2xldCwgUDwvYXV0aG9y

PjxhdXRob3I+QXBhcmljaW8sIEpSPC9hdXRob3I+PGF1dGhvcj5EaW5pcy1SaWJlaXJvLCBNPC9h

dXRob3I+PGF1dGhvcj5HaW9zdHJhLCBFPC9hdXRob3I+PGF1dGhvcj5PcnRtYW5uLCBNPC9hdXRo

b3I+PGF1dGhvcj5LbmFwZSwgSlRBPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0

aXRsZXM+PHRpdGxlPkV1cm9wZWFuIGN1cnJpY3VsdW0gZm9yIHNlZGF0aW9uIHRyYWluaW5nIGlu

IGdhc3Ryb2ludGVzdGluYWwgZW5kb3Njb3B5OiBwb3NpdGlvbiBzdGF0ZW1lbnQgb2YgdGhlIEV1

cm9wZWFuIFNvY2lldHkgb2YgR2FzdHJvaW50ZXN0aW5hbCBFbmRvc2NvcHkgKEVTR0UpIGFuZCBF

dXJvcGVhbiBTb2NpZXR5IG9mIEdhc3Ryb2VudGVyb2xvZ3kgYW5kIEVuZG9zY29weSBOdXJzZXMg

YW5kIEFzc29jaWF0ZXMgKEVTR0VOQSk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RW5kb3Njb3B5

PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RW5kb3Nj

b3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3Njb3B5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxw

YWdlcz40OTYtNTA0PC9wYWdlcz48dm9sdW1lPjQ1PC92b2x1bWU+PG51bWJlcj48c3R5bGUgZmFj

ZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEwMCUiPjY8L3N0

eWxlPjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEzPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMy03

MjZYPC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4yMzcwMjc3NzwvY3VzdG9tMj48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTA1NS9zLTAwMzMtMTM0NDE0MjwvZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Hcm9zczwvQXV0aG9yPjxZZWFyPjIwMDI8L1llYXI+PFJl

Y051bT4yNzwvUmVjTnVtPjxEaXNwbGF5VGV4dD48c3R5bGUgZmFjZT0ic3VwZXJzY3JpcHQiPlsx

NCwgMjBdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+Mjc8L3JlYy1u

dW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4YWVh

dnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDEzNzE5MiI+Mjc8L2tleT48L2Zv

cmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+

PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj5KZWZmcmV5IEIgR3Jvc3M8L3N0eWxlPjwvYXV0aG9yPjxhdXRo

b3I+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBzaXpl

PSIxMDAlIj5GPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXpl

PSIxMDAlIj5hcm1pbmd0b24sIENUPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPiBQZXRlciBMLiBC

YWlsZXk8L2F1dGhvcj48YXV0aG9yPlJpY2hhcmQgVC4gQ29ubmlzPC9hdXRob3I+PGF1dGhvcj5D

aGFybGVzIEouIENvdGU8L2F1dGhvcj48YXV0aG9yPkZyZWQgRy4gRGF2aXM8L2F1dGhvcj48YXV0

aG9yPkJ1cnRvbiBTLiBFcHN0ZWluPC9hdXRob3I+PGF1dGhvcj5MZXNsZXkgR2lsYmVydHNvbjwv

YXV0aG9yPjxhdXRob3I+RGF2aWQgRy4gTmlja2lub3ZpY2g8L2F1dGhvcj48YXV0aG9yPkpvaG4g

TS4gWmVyd2FzPC9hdXRob3I+PGF1dGhvcj5HcmVnb3J5IFp1Y2Nhcm88L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+UHJhY3RpY2UgZ3VpZGVsaW5lcyBmb3Ig

c2VkYXRpb24gYW5kIGFuYWxnZXNpYSBieSBub24tYW5lc3RoZXNpb2xvZ2lzdHM8L3RpdGxlPjxz

ZWNvbmRhcnktdGl0bGU+QW5lc3RoZXNpb2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48

cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5BbmVzdGhlc2lvbG9neTwvZnVsbC10aXRsZT48YWJici0x

PkFuZXN0aGVzaW9sb2d5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz48c3R5bGUgZmFjZT0i

bm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj4xMDA0LTwvc3R5bGU+PHN0eWxlIGZh

Y2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBzaXplPSIxMDAlIj4xMDwv

c3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+MTc8

L3N0eWxlPjwvcGFnZXM+PHZvbHVtZT45Njwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxkYXRl

cz48eWVhcj4yMDAyPC95ZWFyPjwvZGF0ZXM+PHVybHM+PC91cmxzPjxjdXN0b20yPjExOTY0NjEx

PC9jdXN0b20yPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkR1bW9uY2VhdTwvQXV0aG9y

PjxZZWFyPjIwMTM8L1llYXI+PFJlY051bT4zNzwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+

Mzc8L3JlYy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdz

dnBlNWR4YWVhdnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTU0MTU3MzU4OCI+Mzc8

L2tleT48L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwv

cmVmLXR5cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xk

IiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5EdW1vbmNlYXUsIEotTTwvc3R5bGU+PC9hdXRo

b3I+PGF1dGhvcj5SaXBoYXVzLCBBPC9hdXRob3I+PGF1dGhvcj5CZWlsZW5ob2ZmLCBVPC9hdXRo

b3I+PGF1dGhvcj5WaWxtYW5uLCBQPC9hdXRob3I+PGF1dGhvcj5Ib3Juc2xldCwgUDwvYXV0aG9y

PjxhdXRob3I+QXBhcmljaW8sIEpSPC9hdXRob3I+PGF1dGhvcj5EaW5pcy1SaWJlaXJvLCBNPC9h

dXRob3I+PGF1dGhvcj5HaW9zdHJhLCBFPC9hdXRob3I+PGF1dGhvcj5PcnRtYW5uLCBNPC9hdXRo

b3I+PGF1dGhvcj5LbmFwZSwgSlRBPC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0b3JzPjx0

aXRsZXM+PHRpdGxlPkV1cm9wZWFuIGN1cnJpY3VsdW0gZm9yIHNlZGF0aW9uIHRyYWluaW5nIGlu

IGdhc3Ryb2ludGVzdGluYWwgZW5kb3Njb3B5OiBwb3NpdGlvbiBzdGF0ZW1lbnQgb2YgdGhlIEV1

cm9wZWFuIFNvY2lldHkgb2YgR2FzdHJvaW50ZXN0aW5hbCBFbmRvc2NvcHkgKEVTR0UpIGFuZCBF

dXJvcGVhbiBTb2NpZXR5IG9mIEdhc3Ryb2VudGVyb2xvZ3kgYW5kIEVuZG9zY29weSBOdXJzZXMg

YW5kIEFzc29jaWF0ZXMgKEVTR0VOQSk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+RW5kb3Njb3B5

PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+RW5kb3Nj

b3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3Njb3B5PC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxw

YWdlcz40OTYtNTA0PC9wYWdlcz48dm9sdW1lPjQ1PC92b2x1bWU+PG51bWJlcj48c3R5bGUgZmFj

ZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEwMCUiPjY8L3N0

eWxlPjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDEzPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMy03

MjZYPC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4yMzcwMjc3NzwvY3VzdG9tMj48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTA1NS9zLTAwMzMtMTM0NDE0MjwvZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA [14,20]. In our study, ASA I-II patients were included in the study. There are a variety of studies on sedation applications without anaesthesia personnel in patients undergoing the colonoscopy. Patient-controlled sedation (PCS) studies were conducted in which the patient determined his/her own sedation level with PCA pumpPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DcmVwZWF1PC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48

UmVjTnVtPjE3PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

WzEzLCAyMV08L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNzwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhh

ZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4Mzg5Ij4xNzwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9

ImRlZmF1bHQiIHNpemU9IjEwMCUiPkNyZXBlYXUsIFRob21hczwvc3R5bGU+PC9hdXRob3I+PGF1

dGhvcj5Qb2luY2xvdXgsIExhdXJlbnQ8L2F1dGhvcj48YXV0aG9yPkJvbm55LCBDb3Jpbm5lPC9h

dXRob3I+PGF1dGhvcj5MaWdoZXR0bywgU3lsdmllPC9hdXRob3I+PGF1dGhvcj5KYWZmZXV4LCBQ

YXRyaWNpYTwvYXV0aG9yPjxhdXRob3I+QXJ0aWd1ZSwgRmFicmljZTwvYXV0aG9yPjxhdXRob3I+

V2FsbGVja3gsIFBpZXJyZTwvYXV0aG9yPjxhdXRob3I+QmF6aW4sIEplYW4gRXRpZW5uZTwvYXV0

aG9yPjxhdXRob3I+RGFwb2lnbnksIE1pY2hlbDwvYXV0aG9yPjxhdXRob3I+Qm9tbWVsYWVyLCBH

aWxsZXM8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+U2ln

bmlmaWNhbmNlIG9mIHBhdGllbnQtY29udHJvbGxlZCBzZWRhdGlvbiBkdXJpbmcgY29sb25vc2Nv

cHk6IFJlc3VsdHMgZnJvbSBhIHByb3NwZWN0aXZlIHJhbmRvbWl6ZWQgY29udHJvbGxlZCBzdHVk

eTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5HYXN0cm9lbnTDqXJvbG9naWUgY2xpbmlxdWUgZXQg

YmlvbG9naXF1ZTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkdhc3Ryb2VudMOpcm9sb2dpZSBjbGluaXF1ZSBldCBiaW9sb2dpcXVlPC9mdWxsLXRpdGxl

PjxhYmJyLTE+R2FzdHJvZW50ZXJvbCBDbGluIEJpb2w8L2FiYnItMT48L3BlcmlvZGljYWw+PHBh

Z2VzPjEwOTAtMTA5NjwvcGFnZXM+PHZvbHVtZT4yOTwvdm9sdW1lPjxudW1iZXI+MTE8L251bWJl

cj48ZGF0ZXM+PHllYXI+MjAwNTwveWVhcj48L2RhdGVzPjxpc2JuPjAzOTktODMyMDwvaXNibj48

dXJscz48L3VybHM+PGN1c3RvbTI+MTY1MDU3NTM8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjEwLjEwMTYvUzAzOTktODMyMCgwNSk4MjE3Mi00PC9lbGVjdHJvbmljLXJlc291cmNl

LW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5TdWx0YW48L0F1dGhvcj48WWVhcj4y

MDE0PC9ZZWFyPjxSZWNOdW0+OTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+OTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2

cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4Mjk3Ij45PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVm

YXVsdCIgc2l6ZT0iMTAwJSI+U3VsdGFuLCBTaGVyaWYgUzwvc3R5bGU+PC9hdXRob3I+PC9hdXRo

b3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlBhdGllbnQtY29udHJvbGxlZCBzZWRh

dGlvbiB3aXRoIHByb3BvZm9sL3JlbWlmZW50YW5pbCB2ZXJzdXMgcHJvcG9mb2wvYWxmZW50YW5p

bCBmb3IgcGF0aWVudHMgdW5kZXJnb2luZyBvdXRwYXRpZW50IGNvbG9ub3Njb3B5LCBhIHJhbmRv

bWl6ZWQsIGNvbnRyb2xsZWQgZG91YmxlLWJsaW5kIHN0dWR5PC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPlNhdWRpIGpvdXJuYWwgb2YgYW5hZXN0aGVzaWE8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5TYXVkaSBqb3VybmFsIG9mIGFuYWVzdGhlc2lhPC9m

dWxsLXRpdGxlPjxhYmJyLTE+U2F1ZGkgSiBBbmFlc3RoPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxw

YWdlcz48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj4zNjwv

c3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBz

aXplPSIxMDAlIj4tNDA8L3N0eWxlPjwvcGFnZXM+PHZvbHVtZT44PC92b2x1bWU+PG51bWJlcj48

c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEw

MCUiPjU8L3N0eWxlPjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjwvZGF0ZXM+PHVy

bHM+PC91cmxzPjxjdXN0b20yPjI1NTM4NTE4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC40MTAzLzE2NTgtMzU0WC4xNDQwNjg8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwv

cmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5DcmVwZWF1PC9BdXRob3I+PFllYXI+MjAwNTwvWWVhcj48

UmVjTnVtPjE3PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+

WzEzLCAyMV08L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4xNzwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhh

ZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4Mzg5Ij4xNzwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9

ImRlZmF1bHQiIHNpemU9IjEwMCUiPkNyZXBlYXUsIFRob21hczwvc3R5bGU+PC9hdXRob3I+PGF1

dGhvcj5Qb2luY2xvdXgsIExhdXJlbnQ8L2F1dGhvcj48YXV0aG9yPkJvbm55LCBDb3Jpbm5lPC9h

dXRob3I+PGF1dGhvcj5MaWdoZXR0bywgU3lsdmllPC9hdXRob3I+PGF1dGhvcj5KYWZmZXV4LCBQ

YXRyaWNpYTwvYXV0aG9yPjxhdXRob3I+QXJ0aWd1ZSwgRmFicmljZTwvYXV0aG9yPjxhdXRob3I+

V2FsbGVja3gsIFBpZXJyZTwvYXV0aG9yPjxhdXRob3I+QmF6aW4sIEplYW4gRXRpZW5uZTwvYXV0

aG9yPjxhdXRob3I+RGFwb2lnbnksIE1pY2hlbDwvYXV0aG9yPjxhdXRob3I+Qm9tbWVsYWVyLCBH

aWxsZXM8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+U2ln

bmlmaWNhbmNlIG9mIHBhdGllbnQtY29udHJvbGxlZCBzZWRhdGlvbiBkdXJpbmcgY29sb25vc2Nv

cHk6IFJlc3VsdHMgZnJvbSBhIHByb3NwZWN0aXZlIHJhbmRvbWl6ZWQgY29udHJvbGxlZCBzdHVk

eTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5HYXN0cm9lbnTDqXJvbG9naWUgY2xpbmlxdWUgZXQg

YmlvbG9naXF1ZTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRp

dGxlPkdhc3Ryb2VudMOpcm9sb2dpZSBjbGluaXF1ZSBldCBiaW9sb2dpcXVlPC9mdWxsLXRpdGxl

PjxhYmJyLTE+R2FzdHJvZW50ZXJvbCBDbGluIEJpb2w8L2FiYnItMT48L3BlcmlvZGljYWw+PHBh

Z2VzPjEwOTAtMTA5NjwvcGFnZXM+PHZvbHVtZT4yOTwvdm9sdW1lPjxudW1iZXI+MTE8L251bWJl

cj48ZGF0ZXM+PHllYXI+MjAwNTwveWVhcj48L2RhdGVzPjxpc2JuPjAzOTktODMyMDwvaXNibj48

dXJscz48L3VybHM+PGN1c3RvbTI+MTY1MDU3NTM8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3Vy

Y2UtbnVtPjEwLjEwMTYvUzAzOTktODMyMCgwNSk4MjE3Mi00PC9lbGVjdHJvbmljLXJlc291cmNl

LW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5TdWx0YW48L0F1dGhvcj48WWVhcj4y

MDE0PC9ZZWFyPjxSZWNOdW0+OTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+OTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2

cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4Mjk3Ij45PC9rZXk+PC9mb3Jl

aWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxj

b250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVm

YXVsdCIgc2l6ZT0iMTAwJSI+U3VsdGFuLCBTaGVyaWYgUzwvc3R5bGU+PC9hdXRob3I+PC9hdXRo

b3JzPjwvY29udHJpYnV0b3JzPjx0aXRsZXM+PHRpdGxlPlBhdGllbnQtY29udHJvbGxlZCBzZWRh

dGlvbiB3aXRoIHByb3BvZm9sL3JlbWlmZW50YW5pbCB2ZXJzdXMgcHJvcG9mb2wvYWxmZW50YW5p

bCBmb3IgcGF0aWVudHMgdW5kZXJnb2luZyBvdXRwYXRpZW50IGNvbG9ub3Njb3B5LCBhIHJhbmRv

bWl6ZWQsIGNvbnRyb2xsZWQgZG91YmxlLWJsaW5kIHN0dWR5PC90aXRsZT48c2Vjb25kYXJ5LXRp

dGxlPlNhdWRpIGpvdXJuYWwgb2YgYW5hZXN0aGVzaWE8L3NlY29uZGFyeS10aXRsZT48L3RpdGxl

cz48cGVyaW9kaWNhbD48ZnVsbC10aXRsZT5TYXVkaSBqb3VybmFsIG9mIGFuYWVzdGhlc2lhPC9m

dWxsLXRpdGxlPjxhYmJyLTE+U2F1ZGkgSiBBbmFlc3RoPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxw

YWdlcz48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj4zNjwv

c3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0iMTYyIiBz

aXplPSIxMDAlIj4tNDA8L3N0eWxlPjwvcGFnZXM+PHZvbHVtZT44PC92b2x1bWU+PG51bWJlcj48

c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBjaGFyc2V0PSIxNjIiIHNpemU9IjEw

MCUiPjU8L3N0eWxlPjwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDE0PC95ZWFyPjwvZGF0ZXM+PHVy

bHM+PC91cmxzPjxjdXN0b20yPjI1NTM4NTE4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNl

LW51bT4xMC40MTAzLzE2NTgtMzU0WC4xNDQwNjg8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwv

cmVjb3JkPjwvQ2l0ZT48L0VuZE5vdGU+AG==

ADDIN EN.CITE.DATA [13,21]. In this method, the patients press the button when they feel uncomfortable. A certain period of time passes until they are sedated. In these studies, it is mentioned that patients suffer from pain, although not severe. Feeling pain and time to get sedated may cause patients to opt out the method. For this reason, sedation practices under the SSEN are increasing rapidly in recent years. It has been shown in several studies that sedation and colonoscopy practices under the SSEN are safe and effectivePEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWVnPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjEyPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzE5

LCAyMiwgMjNdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTI8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4

YWVhdnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDA2ODMxNiI+MTI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250

PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5TaWVnLCBBPC9zdHlsZT48L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+UHJvcG9mb2wgc2VkYXRpb24gaW4gb3V0cGF0

aWVudCBjb2xvbm9zY29weSBieSB0cmFpbmVkIHByYWN0aWNlIG51cnNlcyBzdXBlcnZpc2VkIGJ5

IHRoZSBnYXN0cm9lbnRlcm9sb2dpc3Q6IGEgcHJvc3BlY3RpdmUgZXZhbHVhdGlvbiBvZiBvdmVy

IDMwMDAgY2FzZXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+WmVpdHNjaHJpZnQgZnVyIEdhc3Ry

b2VudGVyb2xvZ2llPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+WmVpdHNjaHJpZnQgZnVyIEdhc3Ryb2VudGVyb2xvZ2llPC9mdWxsLXRpdGxlPjxhYmJy

LTE+WiBHYXN0cm9lbnRlcm9sPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz42OTctNzAxPC9w

YWdlcz48dm9sdW1lPjQ1PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIw

MDc8L3llYXI+PC9kYXRlcz48aXNibj4wMDQ0LTI3NzE8L2lzYm4+PHVybHM+PC91cmxzPjxjdXN0

b20yPjE3NzAxODU4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDU1L3Mt

MjAwNy05NjMzNDk8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPlRvaGRhPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48UmVjTnVtPjExPC9SZWNO

dW0+PHJlY29yZD48cmVjLW51bWJlcj4xMTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkg

YXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGlt

ZXN0YW1wPSIxNTM0MDY4MzEwIj4xMTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPlRvaGRh

LCBHPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPkhpZ2FzaGksIFM8L2F1dGhvcj48YXV0aG9yPldh

a2FoYXJhLCBTPC9hdXRob3I+PGF1dGhvcj5Nb3Jpa2F3YSwgTTwvYXV0aG9yPjxhdXRob3I+U2Fr

dW1vdG8sIEg8L2F1dGhvcj48YXV0aG9yPkthbmUsIFQ8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+UHJvcG9mb2wgc2VkYXRpb24gZHVyaW5nIGVuZG9zY29w

aWMgcHJvY2VkdXJlczogc2FmZSBhbmQgZWZmZWN0aXZlIGFkbWluaXN0cmF0aW9uIGJ5IHJlZ2lz

dGVyZWQgbnVyc2VzIHN1cGVydmlzZWQgYnkgZW5kb3Njb3Bpc3RzPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkVuZG9zY29weTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxm

dWxsLXRpdGxlPkVuZG9zY29weTwvZnVsbC10aXRsZT48YWJici0xPkVuZG9zY29weTwvYWJici0x

PjwvcGVyaW9kaWNhbD48cGFnZXM+MzYwLTM2NzwvcGFnZXM+PHZvbHVtZT4zODwvdm9sdW1lPjxu

dW1iZXI+NDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAx

My03MjZYPC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xNjY4MDYzNTwvY3VzdG9tMj48ZWxl

Y3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA1NS9zLTIwMDUtOTIxMTkyPC9lbGVjdHJvbmljLXJl

c291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5XYWxrZXI8L0F1dGhvcj48

WWVhcj4yMDAzPC9ZZWFyPjxSZWNOdW0+MTA8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEw

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3Zw

ZTVkeGFlYXZyNnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgzMDQiPjEwPC9r

ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl

Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIg

Zm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+V2Fsa2VyLCBKb2huIEE8L3N0eWxlPjwvYXV0aG9y

PjxhdXRob3I+TWNJbnR5cmUsIFJvYmVydCBEPC9hdXRob3I+PGF1dGhvcj5TY2hsZWluaXR6LCBQ

YXVsIEY8L2F1dGhvcj48YXV0aG9yPkphY29ic29uLCBLcmlzIE48L2F1dGhvcj48YXV0aG9yPkhh

dWxrLCBBbnRob255IEE8L2F1dGhvcj48YXV0aG9yPkFkZXNtYW4sIFBldGVyPC9hdXRob3I+PGF1

dGhvcj5Ub2xsZXNvbiwgU2hlbGxleTwvYXV0aG9yPjxhdXRob3I+UGFyZW50LCBSb2J5bjwvYXV0

aG9yPjxhdXRob3I+RG9ubmVsbHksIFJvc2llPC9hdXRob3I+PGF1dGhvcj5SZXgsIERvdWdsYXMg

SzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5OdXJzZS1h

ZG1pbmlzdGVyZWQgcHJvcG9mb2wgc2VkYXRpb24gd2l0aG91dCBhbmVzdGhlc2lhIHNwZWNpYWxp

c3RzIGluIDkxNTIgZW5kb3Njb3BpYyBjYXNlcyBpbiBhbiBhbWJ1bGF0b3J5IHN1cmdlcnkgY2Vu

dGVyPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPlRoZSBBbWVyaWNhbiBqb3VybmFsIG9mIGdhc3Ry

b2VudGVyb2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0cm9lbnRlcm9sb2d5PC9mdWxsLXRpdGxl

PjxhYmJyLTE+QW0gSiBHYXN0cm9lbnRlcm9sPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4x

NzQ0LTE3NTA8L3BhZ2VzPjx2b2x1bWU+OTg8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAwMzwveWVhcj48L2RhdGVzPjxpc2JuPjAwMDItOTI3MDwvaXNibj48dXJscz48

L3VybHM+PGN1c3RvbTI+MTI5MDczMjg8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjExMTEvai4xNTcyLTAyNDEuMjAwMy4wNzYwNS54PC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaWVnPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjEyPC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzE5

LCAyMiwgMjNdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MTI8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4

YWVhdnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDA2ODMxNiI+MTI8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250

PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5TaWVnLCBBPC9zdHlsZT48L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+UHJvcG9mb2wgc2VkYXRpb24gaW4gb3V0cGF0

aWVudCBjb2xvbm9zY29weSBieSB0cmFpbmVkIHByYWN0aWNlIG51cnNlcyBzdXBlcnZpc2VkIGJ5

IHRoZSBnYXN0cm9lbnRlcm9sb2dpc3Q6IGEgcHJvc3BlY3RpdmUgZXZhbHVhdGlvbiBvZiBvdmVy

IDMwMDAgY2FzZXM8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+WmVpdHNjaHJpZnQgZnVyIEdhc3Ry

b2VudGVyb2xvZ2llPC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+WmVpdHNjaHJpZnQgZnVyIEdhc3Ryb2VudGVyb2xvZ2llPC9mdWxsLXRpdGxlPjxhYmJy

LTE+WiBHYXN0cm9lbnRlcm9sPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz42OTctNzAxPC9w

YWdlcz48dm9sdW1lPjQ1PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIw

MDc8L3llYXI+PC9kYXRlcz48aXNibj4wMDQ0LTI3NzE8L2lzYm4+PHVybHM+PC91cmxzPjxjdXN0

b20yPjE3NzAxODU4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDU1L3Mt

MjAwNy05NjMzNDk8L2VsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0

ZT48QXV0aG9yPlRvaGRhPC9BdXRob3I+PFllYXI+MjAwNjwvWWVhcj48UmVjTnVtPjExPC9SZWNO

dW0+PHJlY29yZD48cmVjLW51bWJlcj4xMTwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkg

YXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGlt

ZXN0YW1wPSIxNTM0MDY4MzEwIj4xMTwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1l

PSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxh

dXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPlRvaGRh

LCBHPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPkhpZ2FzaGksIFM8L2F1dGhvcj48YXV0aG9yPldh

a2FoYXJhLCBTPC9hdXRob3I+PGF1dGhvcj5Nb3Jpa2F3YSwgTTwvYXV0aG9yPjxhdXRob3I+U2Fr

dW1vdG8sIEg8L2F1dGhvcj48YXV0aG9yPkthbmUsIFQ8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250

cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+UHJvcG9mb2wgc2VkYXRpb24gZHVyaW5nIGVuZG9zY29w

aWMgcHJvY2VkdXJlczogc2FmZSBhbmQgZWZmZWN0aXZlIGFkbWluaXN0cmF0aW9uIGJ5IHJlZ2lz

dGVyZWQgbnVyc2VzIHN1cGVydmlzZWQgYnkgZW5kb3Njb3Bpc3RzPC90aXRsZT48c2Vjb25kYXJ5

LXRpdGxlPkVuZG9zY29weTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxm

dWxsLXRpdGxlPkVuZG9zY29weTwvZnVsbC10aXRsZT48YWJici0xPkVuZG9zY29weTwvYWJici0x

PjwvcGVyaW9kaWNhbD48cGFnZXM+MzYwLTM2NzwvcGFnZXM+PHZvbHVtZT4zODwvdm9sdW1lPjxu

dW1iZXI+NDwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDA2PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAx

My03MjZYPC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xNjY4MDYzNTwvY3VzdG9tMj48ZWxl

Y3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA1NS9zLTIwMDUtOTIxMTkyPC9lbGVjdHJvbmljLXJl

c291cmNlLW51bT48L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5XYWxrZXI8L0F1dGhvcj48

WWVhcj4yMDAzPC9ZZWFyPjxSZWNOdW0+MTA8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjEw

PC9yZWMtbnVtYmVyPjxmb3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3Zw

ZTVkeGFlYXZyNnZzeDkyZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgzMDQiPjEwPC9r

ZXk+PC9mb3JlaWduLWtleXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3Jl

Zi10eXBlPjxjb250cmlidXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIg

Zm9udD0iZGVmYXVsdCIgc2l6ZT0iMTAwJSI+V2Fsa2VyLCBKb2huIEE8L3N0eWxlPjwvYXV0aG9y

PjxhdXRob3I+TWNJbnR5cmUsIFJvYmVydCBEPC9hdXRob3I+PGF1dGhvcj5TY2hsZWluaXR6LCBQ

YXVsIEY8L2F1dGhvcj48YXV0aG9yPkphY29ic29uLCBLcmlzIE48L2F1dGhvcj48YXV0aG9yPkhh

dWxrLCBBbnRob255IEE8L2F1dGhvcj48YXV0aG9yPkFkZXNtYW4sIFBldGVyPC9hdXRob3I+PGF1

dGhvcj5Ub2xsZXNvbiwgU2hlbGxleTwvYXV0aG9yPjxhdXRob3I+UGFyZW50LCBSb2J5bjwvYXV0

aG9yPjxhdXRob3I+RG9ubmVsbHksIFJvc2llPC9hdXRob3I+PGF1dGhvcj5SZXgsIERvdWdsYXMg

SzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5OdXJzZS1h

ZG1pbmlzdGVyZWQgcHJvcG9mb2wgc2VkYXRpb24gd2l0aG91dCBhbmVzdGhlc2lhIHNwZWNpYWxp

c3RzIGluIDkxNTIgZW5kb3Njb3BpYyBjYXNlcyBpbiBhbiBhbWJ1bGF0b3J5IHN1cmdlcnkgY2Vu

dGVyPC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPlRoZSBBbWVyaWNhbiBqb3VybmFsIG9mIGdhc3Ry

b2VudGVyb2xvZ3k8L3NlY29uZGFyeS10aXRsZT48L3RpdGxlcz48cGVyaW9kaWNhbD48ZnVsbC10

aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0cm9lbnRlcm9sb2d5PC9mdWxsLXRpdGxl

PjxhYmJyLTE+QW0gSiBHYXN0cm9lbnRlcm9sPC9hYmJyLTE+PC9wZXJpb2RpY2FsPjxwYWdlcz4x

NzQ0LTE3NTA8L3BhZ2VzPjx2b2x1bWU+OTg8L3ZvbHVtZT48bnVtYmVyPjg8L251bWJlcj48ZGF0

ZXM+PHllYXI+MjAwMzwveWVhcj48L2RhdGVzPjxpc2JuPjAwMDItOTI3MDwvaXNibj48dXJscz48

L3VybHM+PGN1c3RvbTI+MTI5MDczMjg8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjExMTEvai4xNTcyLTAyNDEuMjAwMy4wNzYwNS54PC9lbGVjdHJvbmljLXJlc291cmNlLW51

bT48L3JlY29yZD48L0NpdGU+PC9FbmROb3RlPn==

ADDIN EN.CITE.DATA [19,22,23]. In a study comparing PCS with SSEN, it has been shown that many patients prefer SSEN instead of PCS because of the anxiety they feel ADDIN EN.CITE <EndNote><Cite><Author>Heuss</Author><Year>2004</Year><RecNum>28</RecNum><DisplayText><style face="superscript">[24]</style></DisplayText><record><rec-number>28</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534271690">28</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Heuss, Ludwig T</style></author><author>Drewe, Juergen</author><author>Schnieper, Patrizia</author><author>Tapparelli, Claudia B</author><author>Pflimlin, Eric</author><author>Beglinger, Christoph</author></authors></contributors><titles><title>Patient-controlled versus nurse-administered sedation with propofol during colonoscopy. A prospective randomized trial</title><secondary-title>The American journal of gastroenterology</secondary-title></titles><periodical><full-title>The American journal of gastroenterology</full-title><abbr-1>Am J Gastroenterol</abbr-1></periodical><pages><style face="normal" font="default" size="100%">511</style><style face="normal" font="default" charset="162" size="100%">-518</style></pages><volume>99</volume><number>3</number><dates><year>2004</year></dates><isbn>1572-0241</isbn><urls></urls><custom2>15056094</custom2><electronic-resource-num>10.1111/j.1572-0241.2004.04088.x</electronic-resource-num></record></Cite></EndNote>[24]. We also preferred SSEN instead of PCS in our study. We applied propofol with the PCA pump in order to reduce the human-caused mistakes. The PCA pump allows us to easily dispense the right dose of medicine repeatedly without requiring our attention.In the study by Poon et al ADDIN EN.CITE <EndNote><Cite><Author>Poon</Author><Year>2007</Year><RecNum>29</RecNum><DisplayText><style face="superscript">[25]</style></DisplayText><record><rec-number>29</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534271766">29</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Poon, Chi-Ming</style></author><author>Leung, Tak-Lun</author><author>Wong, Chui-Wah</author><author>Chan, Yuk-Ling</author><author>Leung, Tin-Chun</author><author>Leong, Heng-Tat</author></authors></contributors><titles><title>Safety of nurse-administered propofol sedation using PCA pump for outpatient colonoscopy in Chinese patients: a pilot study</title><secondary-title><style face="normal" font="default" size="100%">Asian Journal of </style><style face="normal" font="default" charset="162" size="100%">S</style><style face="normal" font="default" size="100%">urgery</style></secondary-title></titles><periodical><full-title>Asian Journal of surgery</full-title><abbr-1>Asian J Surg</abbr-1></periodical><pages>239-243</pages><volume>30</volume><number>4</number><dates><year>2007</year></dates><isbn>1015-9584</isbn><urls></urls><custom2>17962125 </custom2><electronic-resource-num>10.1016/S1015-9584(08)60032-9</electronic-resource-num></record></Cite></EndNote>[25], it was found that SSEN with PCA pump was effective and safe in healthy individuals who would undergo colonoscopy. In another study by Liu et al ADDIN EN.CITE <EndNote><Cite><Author>Liu</Author><Year>2009</Year><RecNum>15</RecNum><DisplayText><style face="superscript">[26]</style></DisplayText><record><rec-number>15</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068334">15</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Liu, SYW</style></author><author>Poon, CM</author><author>Leung, TL</author><author>Wong, CW</author><author>Chan, YL</author><author>Leong, HT</author></authors></contributors><titles><title>Nurse-administered propofol–alfentanil sedation using a patient-controlled analgesia pump compared with opioid–benzodiazepine sedation for outpatient colonoscopy</title><secondary-title>Endoscopy</secondary-title></titles><periodical><full-title>Endoscopy</full-title><abbr-1>Endoscopy</abbr-1></periodical><pages>522-528</pages><volume>41</volume><number>6</number><dates><year>2009</year></dates><isbn>0013-726X</isbn><urls></urls><custom2>19440955</custom2><electronic-resource-num>10.1055/s-0029-1214711</electronic-resource-num></record></Cite></EndNote>[26], while a group was administered propofol-alfentanil by method of SSEN with PCA pump, opioid-benzodiazepine was administered to the other group by the anaesthetist. As a result of the study, there was no significant difference between groups in terms of side effects, pain scores, and the willingness to repeat the colonoscopy with the same sedation method. In the SSEN group, it was stated that only deeper sedation was obtained. Since two sets of sedation protocols were applied, it was thought that this situation was caused by the difference in drug combinations used rather than SSEN method.In a sedation protocol, the total amount of drug used is reduced due to the synergistic effect of drugs on each other formed by adding adjuvant drugs in addition to propofol ADDIN EN.CITE <EndNote><Cite><Author>Joo</Author><Year>2001</Year><RecNum>20</RecNum><DisplayText><style face="superscript">[6]</style></DisplayText><record><rec-number>20</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068409">20</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Joo, Hwan S</style></author><author>Perks, William J</author><author>Kataoka, Mark T</author><author>Errett, Lee</author><author>Pace, Kenneth</author><author>Honey, R John</author></authors></contributors><titles><title>A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy</title><secondary-title>Anesthesia &amp; Analgesia</secondary-title></titles><periodical><full-title>Anesthesia &amp; Analgesia</full-title><abbr-1>Anesth Analg</abbr-1></periodical><pages>1227-1232</pages><volume>93</volume><number>5</number><dates><year>2001</year></dates><isbn>0003-2999</isbn><urls></urls><custom2>11682403</custom2><electronic-resource-num>10.1097/00000539-200111000-00037</electronic-resource-num></record></Cite></EndNote>[6]. Total doses of propofol used in previous studies ranged from 124 to 188 mgPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qb29uPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjI5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzE5

LCAyNS0yOF08L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yOTwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhh

ZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MjcxNzY2Ij4yOTwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9

ImRlZmF1bHQiIHNpemU9IjEwMCUiPlBvb24sIENoaS1NaW5nPC9zdHlsZT48L2F1dGhvcj48YXV0

aG9yPkxldW5nLCBUYWstTHVuPC9hdXRob3I+PGF1dGhvcj5Xb25nLCBDaHVpLVdhaDwvYXV0aG9y

PjxhdXRob3I+Q2hhbiwgWXVrLUxpbmc8L2F1dGhvcj48YXV0aG9yPkxldW5nLCBUaW4tQ2h1bjwv

YXV0aG9yPjxhdXRob3I+TGVvbmcsIEhlbmctVGF0PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJp

YnV0b3JzPjx0aXRsZXM+PHRpdGxlPlNhZmV0eSBvZiBudXJzZS1hZG1pbmlzdGVyZWQgcHJvcG9m

b2wgc2VkYXRpb24gdXNpbmcgUENBIHB1bXAgZm9yIG91dHBhdGllbnQgY29sb25vc2NvcHkgaW4g

Q2hpbmVzZSBwYXRpZW50czogYSBwaWxvdCBzdHVkeTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT48

c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5Bc2lhbiBKb3Vy

bmFsIG9mIDwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNl

dD0iMTYyIiBzaXplPSIxMDAlIj5TPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj51cmdlcnk8L3N0eWxlPjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0

bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFzaWFuIEpvdXJuYWwgb2Ygc3VyZ2VyeTwvZnVs

bC10aXRsZT48YWJici0xPkFzaWFuIEogU3VyZzwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+

MjM5LTI0MzwvcGFnZXM+PHZvbHVtZT4zMDwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxkYXRl

cz48eWVhcj4yMDA3PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTAxNS05NTg0PC9pc2JuPjx1cmxzPjwv

dXJscz48Y3VzdG9tMj4xNzk2MjEyNSA8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjEwMTYvUzEwMTUtOTU4NCgwOCk2MDAzMi05PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5MaXU8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFy

PjxSZWNOdW0+MTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE1PC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZyNnZzeDky

ZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgzMzQiPjE1PC9rZXk+PC9mb3JlaWduLWtl

eXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmli

dXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVmYXVsdCIg

c2l6ZT0iMTAwJSI+TGl1LCBTWVc8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+UG9vbiwgQ008L2F1

dGhvcj48YXV0aG9yPkxldW5nLCBUTDwvYXV0aG9yPjxhdXRob3I+V29uZywgQ1c8L2F1dGhvcj48

YXV0aG9yPkNoYW4sIFlMPC9hdXRob3I+PGF1dGhvcj5MZW9uZywgSFQ8L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2UtYWRtaW5pc3RlcmVkIHByb3Bv

Zm9s4oCTYWxmZW50YW5pbCBzZWRhdGlvbiB1c2luZyBhIHBhdGllbnQtY29udHJvbGxlZCBhbmFs

Z2VzaWEgcHVtcCBjb21wYXJlZCB3aXRoIG9waW9pZOKAk2JlbnpvZGlhemVwaW5lIHNlZGF0aW9u

IGZvciBvdXRwYXRpZW50IGNvbG9ub3Njb3B5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVuZG9z

Y29weTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkVu

ZG9zY29weTwvZnVsbC10aXRsZT48YWJici0xPkVuZG9zY29weTwvYWJici0xPjwvcGVyaW9kaWNh

bD48cGFnZXM+NTIyLTUyODwvcGFnZXM+PHZvbHVtZT40MTwvdm9sdW1lPjxudW1iZXI+NjwvbnVt

YmVyPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMy03MjZYPC9pc2Ju

Pjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xOTQ0MDk1NTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+MTAuMTA1NS9zLTAwMjktMTIxNDcxMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+

PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+U2lwZTwvQXV0aG9yPjxZZWFyPjIwMDI8L1ll

YXI+PFJlY051bT4zNTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MzU8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4YWVhdnI2dnN4

OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDQ1MDkwOCI+MzU8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0

IiBzaXplPSIxMDAlIj5TaXBlLCBCcmlhbiBXPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPlJleCwg

RG91Z2xhcyBLPC9hdXRob3I+PGF1dGhvcj5MYXRpbm92aWNoLCBEYW5pZWxsZTwvYXV0aG9yPjxh

dXRob3I+T3ZlcmxleSwgQ2hyaXM8L2F1dGhvcj48YXV0aG9yPktpbnNlciwgS2FyZW48L2F1dGhv

cj48YXV0aG9yPkJyYXRjaGVyLCBMaXNhPC9hdXRob3I+PGF1dGhvcj5LYXJla2VuLCBEYXZpZDwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Qcm9wb2ZvbCB2

ZXJzdXMgbWlkYXpvbGFtL21lcGVyaWRpbmUgZm9yIG91dHBhdGllbnQgY29sb25vc2NvcHk6IGFk

bWluaXN0cmF0aW9uIGJ5IG51cnNlcyBzdXBlcnZpc2VkIGJ5IGVuZG9zY29waXN0czwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5HYXN0cm9pbnRlc3RpbmFsIGVuZG9zY29weTwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkdhc3Ryb2ludGVzdGluYWwgZW5k

b3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+R2FzdHJvaW50ZXN0IEVuZG9zYzwvYWJici0xPjwv

cGVyaW9kaWNhbD48cGFnZXM+ODE1LTgyNTwvcGFnZXM+PHZvbHVtZT41NTwvdm9sdW1lPjxudW1i

ZXI+NzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAyPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxNi01

MTA3PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xMjAyNDEzNDwvY3VzdG9tMj48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTA2Ny9tZ2UuMjAwMi4xMjQ2MzY8L2VsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkvDvGxsaW5nPC9BdXRob3I+

PFllYXI+MjAwMzwvWWVhcj48UmVjTnVtPjM2PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4z

NjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2

cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0NDUxMDA1Ij4zNjwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQi

IGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPkvDvGxsaW5nLCBEPC9zdHlsZT48L2F1dGhvcj48

YXV0aG9yPlJvdGhlbmLDvGhsZXIsIFI8L2F1dGhvcj48YXV0aG9yPkluYXVlbiwgVzwvYXV0aG9y

PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5TYWZldHkgb2Ygbm9uYW5l

c3RoZXRpc3Qgc2VkYXRpb24gd2l0aCBwcm9wb2ZvbCBmb3Igb3V0cGF0aWVudCBjb2xvbm9zY29w

eSBhbmQgZXNvcGhhZ29nYXN0cm9kdW9kZW5vc2NvcHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

RW5kb3Njb3B5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0

bGU+RW5kb3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3Njb3B5PC9hYmJyLTE+PC9wZXJp

b2RpY2FsPjxwYWdlcz42NzktNjgyPC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+PG51bWJlcj44

PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4wMDEzLTcyNlg8

L2lzYm4+PHVybHM+PC91cmxzPjxjdXN0b20yPjEyOTI5MDY0PC9jdXN0b20yPjxlbGVjdHJvbmlj

LXJlc291cmNlLW51bT4xMC4xMDU1L3MtMjAwMy00MTUxODwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u

dW0+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+V2Fsa2VyPC9BdXRob3I+PFllYXI+MjAw

MzwvWWVhcj48UmVjTnVtPjEwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xMDwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2

cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4MzA0Ij4xMDwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRl

ZmF1bHQiIHNpemU9IjEwMCUiPldhbGtlciwgSm9obiBBPC9zdHlsZT48L2F1dGhvcj48YXV0aG9y

Pk1jSW50eXJlLCBSb2JlcnQgRDwvYXV0aG9yPjxhdXRob3I+U2NobGVpbml0eiwgUGF1bCBGPC9h

dXRob3I+PGF1dGhvcj5KYWNvYnNvbiwgS3JpcyBOPC9hdXRob3I+PGF1dGhvcj5IYXVsaywgQW50

aG9ueSBBPC9hdXRob3I+PGF1dGhvcj5BZGVzbWFuLCBQZXRlcjwvYXV0aG9yPjxhdXRob3I+VG9s

bGVzb24sIFNoZWxsZXk8L2F1dGhvcj48YXV0aG9yPlBhcmVudCwgUm9ieW48L2F1dGhvcj48YXV0

aG9yPkRvbm5lbGx5LCBSb3NpZTwvYXV0aG9yPjxhdXRob3I+UmV4LCBEb3VnbGFzIEs8L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2UtYWRtaW5pc3Rl

cmVkIHByb3BvZm9sIHNlZGF0aW9uIHdpdGhvdXQgYW5lc3RoZXNpYSBzcGVjaWFsaXN0cyBpbiA5

MTUyIGVuZG9zY29waWMgY2FzZXMgaW4gYW4gYW1idWxhdG9yeSBzdXJnZXJ5IGNlbnRlcjwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0cm9lbnRlcm9s

b2d5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+VGhl

IEFtZXJpY2FuIGpvdXJuYWwgb2YgZ2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRsZT48YWJici0x

PkFtIEogR2FzdHJvZW50ZXJvbDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTc0NC0xNzUw

PC9wYWdlcz48dm9sdW1lPjk4PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4wMDAyLTkyNzA8L2lzYm4+PHVybHM+PC91cmxzPjxj

dXN0b20yPjEyOTA3MzI4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMTEx

L2ouMTU3Mi0wMjQxLjIwMDMuMDc2MDUueDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qb29uPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjI5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzE5

LCAyNS0yOF08L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yOTwvcmVj

LW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhh

ZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MjcxNzY2Ij4yOTwva2V5Pjwv

Zm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlw

ZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9

ImRlZmF1bHQiIHNpemU9IjEwMCUiPlBvb24sIENoaS1NaW5nPC9zdHlsZT48L2F1dGhvcj48YXV0

aG9yPkxldW5nLCBUYWstTHVuPC9hdXRob3I+PGF1dGhvcj5Xb25nLCBDaHVpLVdhaDwvYXV0aG9y

PjxhdXRob3I+Q2hhbiwgWXVrLUxpbmc8L2F1dGhvcj48YXV0aG9yPkxldW5nLCBUaW4tQ2h1bjwv

YXV0aG9yPjxhdXRob3I+TGVvbmcsIEhlbmctVGF0PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJp

YnV0b3JzPjx0aXRsZXM+PHRpdGxlPlNhZmV0eSBvZiBudXJzZS1hZG1pbmlzdGVyZWQgcHJvcG9m

b2wgc2VkYXRpb24gdXNpbmcgUENBIHB1bXAgZm9yIG91dHBhdGllbnQgY29sb25vc2NvcHkgaW4g

Q2hpbmVzZSBwYXRpZW50czogYSBwaWxvdCBzdHVkeTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT48

c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5Bc2lhbiBKb3Vy

bmFsIG9mIDwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNl

dD0iMTYyIiBzaXplPSIxMDAlIj5TPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJk

ZWZhdWx0IiBzaXplPSIxMDAlIj51cmdlcnk8L3N0eWxlPjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0

bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFzaWFuIEpvdXJuYWwgb2Ygc3VyZ2VyeTwvZnVs

bC10aXRsZT48YWJici0xPkFzaWFuIEogU3VyZzwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+

MjM5LTI0MzwvcGFnZXM+PHZvbHVtZT4zMDwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxkYXRl

cz48eWVhcj4yMDA3PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTAxNS05NTg0PC9pc2JuPjx1cmxzPjwv

dXJscz48Y3VzdG9tMj4xNzk2MjEyNSA8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVt

PjEwLjEwMTYvUzEwMTUtOTU4NCgwOCk2MDAzMi05PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48

L3JlY29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5MaXU8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFy

PjxSZWNOdW0+MTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE1PC9yZWMtbnVtYmVyPjxm

b3JlaWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZyNnZzeDky

ZXQyNTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgzMzQiPjE1PC9rZXk+PC9mb3JlaWduLWtl

eXM+PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmli

dXRvcnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVmYXVsdCIg

c2l6ZT0iMTAwJSI+TGl1LCBTWVc8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+UG9vbiwgQ008L2F1

dGhvcj48YXV0aG9yPkxldW5nLCBUTDwvYXV0aG9yPjxhdXRob3I+V29uZywgQ1c8L2F1dGhvcj48

YXV0aG9yPkNoYW4sIFlMPC9hdXRob3I+PGF1dGhvcj5MZW9uZywgSFQ8L2F1dGhvcj48L2F1dGhv

cnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2UtYWRtaW5pc3RlcmVkIHByb3Bv

Zm9s4oCTYWxmZW50YW5pbCBzZWRhdGlvbiB1c2luZyBhIHBhdGllbnQtY29udHJvbGxlZCBhbmFs

Z2VzaWEgcHVtcCBjb21wYXJlZCB3aXRoIG9waW9pZOKAk2JlbnpvZGlhemVwaW5lIHNlZGF0aW9u

IGZvciBvdXRwYXRpZW50IGNvbG9ub3Njb3B5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVuZG9z

Y29weTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkVu

ZG9zY29weTwvZnVsbC10aXRsZT48YWJici0xPkVuZG9zY29weTwvYWJici0xPjwvcGVyaW9kaWNh

bD48cGFnZXM+NTIyLTUyODwvcGFnZXM+PHZvbHVtZT40MTwvdm9sdW1lPjxudW1iZXI+NjwvbnVt

YmVyPjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMy03MjZYPC9pc2Ju

Pjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xOTQ0MDk1NTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNv

dXJjZS1udW0+MTAuMTA1NS9zLTAwMjktMTIxNDcxMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+

PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+U2lwZTwvQXV0aG9yPjxZZWFyPjIwMDI8L1ll

YXI+PFJlY051bT4zNTwvUmVjTnVtPjxyZWNvcmQ+PHJlYy1udW1iZXI+MzU8L3JlYy1udW1iZXI+

PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4YWVhdnI2dnN4

OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDQ1MDkwOCI+MzU8L2tleT48L2ZvcmVpZ24t

a2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5cGU+PGNvbnRy

aWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250PSJkZWZhdWx0

IiBzaXplPSIxMDAlIj5TaXBlLCBCcmlhbiBXPC9zdHlsZT48L2F1dGhvcj48YXV0aG9yPlJleCwg

RG91Z2xhcyBLPC9hdXRob3I+PGF1dGhvcj5MYXRpbm92aWNoLCBEYW5pZWxsZTwvYXV0aG9yPjxh

dXRob3I+T3ZlcmxleSwgQ2hyaXM8L2F1dGhvcj48YXV0aG9yPktpbnNlciwgS2FyZW48L2F1dGhv

cj48YXV0aG9yPkJyYXRjaGVyLCBMaXNhPC9hdXRob3I+PGF1dGhvcj5LYXJla2VuLCBEYXZpZDwv

YXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Qcm9wb2ZvbCB2

ZXJzdXMgbWlkYXpvbGFtL21lcGVyaWRpbmUgZm9yIG91dHBhdGllbnQgY29sb25vc2NvcHk6IGFk

bWluaXN0cmF0aW9uIGJ5IG51cnNlcyBzdXBlcnZpc2VkIGJ5IGVuZG9zY29waXN0czwvdGl0bGU+

PHNlY29uZGFyeS10aXRsZT5HYXN0cm9pbnRlc3RpbmFsIGVuZG9zY29weTwvc2Vjb25kYXJ5LXRp

dGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkdhc3Ryb2ludGVzdGluYWwgZW5k

b3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+R2FzdHJvaW50ZXN0IEVuZG9zYzwvYWJici0xPjwv

cGVyaW9kaWNhbD48cGFnZXM+ODE1LTgyNTwvcGFnZXM+PHZvbHVtZT41NTwvdm9sdW1lPjxudW1i

ZXI+NzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAyPC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxNi01

MTA3PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xMjAyNDEzNDwvY3VzdG9tMj48ZWxlY3Ry

b25pYy1yZXNvdXJjZS1udW0+MTAuMTA2Ny9tZ2UuMjAwMi4xMjQ2MzY8L2VsZWN0cm9uaWMtcmVz

b3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkvDvGxsaW5nPC9BdXRob3I+

PFllYXI+MjAwMzwvWWVhcj48UmVjTnVtPjM2PC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4z

NjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2

cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0NDUxMDA1Ij4zNjwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQi

IGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPkvDvGxsaW5nLCBEPC9zdHlsZT48L2F1dGhvcj48

YXV0aG9yPlJvdGhlbmLDvGhsZXIsIFI8L2F1dGhvcj48YXV0aG9yPkluYXVlbiwgVzwvYXV0aG9y

PjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5TYWZldHkgb2Ygbm9uYW5l

c3RoZXRpc3Qgc2VkYXRpb24gd2l0aCBwcm9wb2ZvbCBmb3Igb3V0cGF0aWVudCBjb2xvbm9zY29w

eSBhbmQgZXNvcGhhZ29nYXN0cm9kdW9kZW5vc2NvcHk8L3RpdGxlPjxzZWNvbmRhcnktdGl0bGU+

RW5kb3Njb3B5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0

bGU+RW5kb3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3Njb3B5PC9hYmJyLTE+PC9wZXJp

b2RpY2FsPjxwYWdlcz42NzktNjgyPC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+PG51bWJlcj44

PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4wMDEzLTcyNlg8

L2lzYm4+PHVybHM+PC91cmxzPjxjdXN0b20yPjEyOTI5MDY0PC9jdXN0b20yPjxlbGVjdHJvbmlj

LXJlc291cmNlLW51bT4xMC4xMDU1L3MtMjAwMy00MTUxODwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u

dW0+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+V2Fsa2VyPC9BdXRob3I+PFllYXI+MjAw

MzwvWWVhcj48UmVjTnVtPjEwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4xMDwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2

cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4MzA0Ij4xMDwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRl

ZmF1bHQiIHNpemU9IjEwMCUiPldhbGtlciwgSm9obiBBPC9zdHlsZT48L2F1dGhvcj48YXV0aG9y

Pk1jSW50eXJlLCBSb2JlcnQgRDwvYXV0aG9yPjxhdXRob3I+U2NobGVpbml0eiwgUGF1bCBGPC9h

dXRob3I+PGF1dGhvcj5KYWNvYnNvbiwgS3JpcyBOPC9hdXRob3I+PGF1dGhvcj5IYXVsaywgQW50

aG9ueSBBPC9hdXRob3I+PGF1dGhvcj5BZGVzbWFuLCBQZXRlcjwvYXV0aG9yPjxhdXRob3I+VG9s

bGVzb24sIFNoZWxsZXk8L2F1dGhvcj48YXV0aG9yPlBhcmVudCwgUm9ieW48L2F1dGhvcj48YXV0

aG9yPkRvbm5lbGx5LCBSb3NpZTwvYXV0aG9yPjxhdXRob3I+UmV4LCBEb3VnbGFzIEs8L2F1dGhv

cj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2UtYWRtaW5pc3Rl

cmVkIHByb3BvZm9sIHNlZGF0aW9uIHdpdGhvdXQgYW5lc3RoZXNpYSBzcGVjaWFsaXN0cyBpbiA5

MTUyIGVuZG9zY29waWMgY2FzZXMgaW4gYW4gYW1idWxhdG9yeSBzdXJnZXJ5IGNlbnRlcjwvdGl0

bGU+PHNlY29uZGFyeS10aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0cm9lbnRlcm9s

b2d5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwtdGl0bGU+VGhl

IEFtZXJpY2FuIGpvdXJuYWwgb2YgZ2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRsZT48YWJici0x

PkFtIEogR2FzdHJvZW50ZXJvbDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MTc0NC0xNzUw

PC9wYWdlcz48dm9sdW1lPjk4PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFy

PjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4wMDAyLTkyNzA8L2lzYm4+PHVybHM+PC91cmxzPjxj

dXN0b20yPjEyOTA3MzI4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMTEx

L2ouMTU3Mi0wMjQxLjIwMDMuMDc2MDUueDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9yZWNv

cmQ+PC9DaXRlPjwvRW5kTm90ZT4A

ADDIN EN.CITE.DATA [19,25-28]. Lower levels of propofol were used in studies where propofol was used in combination with other medicinesPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qb29uPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjI5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzI1

LCAyNl08L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yOTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2

cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MjcxNzY2Ij4yOTwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRl

ZmF1bHQiIHNpemU9IjEwMCUiPlBvb24sIENoaS1NaW5nPC9zdHlsZT48L2F1dGhvcj48YXV0aG9y

PkxldW5nLCBUYWstTHVuPC9hdXRob3I+PGF1dGhvcj5Xb25nLCBDaHVpLVdhaDwvYXV0aG9yPjxh

dXRob3I+Q2hhbiwgWXVrLUxpbmc8L2F1dGhvcj48YXV0aG9yPkxldW5nLCBUaW4tQ2h1bjwvYXV0

aG9yPjxhdXRob3I+TGVvbmcsIEhlbmctVGF0PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0

b3JzPjx0aXRsZXM+PHRpdGxlPlNhZmV0eSBvZiBudXJzZS1hZG1pbmlzdGVyZWQgcHJvcG9mb2wg

c2VkYXRpb24gdXNpbmcgUENBIHB1bXAgZm9yIG91dHBhdGllbnQgY29sb25vc2NvcHkgaW4gQ2hp

bmVzZSBwYXRpZW50czogYSBwaWxvdCBzdHVkeTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT48c3R5

bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5Bc2lhbiBKb3VybmFs

IG9mIDwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0i

MTYyIiBzaXplPSIxMDAlIj5TPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZh

dWx0IiBzaXplPSIxMDAlIj51cmdlcnk8L3N0eWxlPjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVz

PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFzaWFuIEpvdXJuYWwgb2Ygc3VyZ2VyeTwvZnVsbC10

aXRsZT48YWJici0xPkFzaWFuIEogU3VyZzwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MjM5

LTI0MzwvcGFnZXM+PHZvbHVtZT4zMDwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxkYXRlcz48

eWVhcj4yMDA3PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTAxNS05NTg0PC9pc2JuPjx1cmxzPjwvdXJs

cz48Y3VzdG9tMj4xNzk2MjEyNSA8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEw

LjEwMTYvUzEwMTUtOTU4NCgwOCk2MDAzMi05PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5MaXU8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+MTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE1PC9yZWMtbnVtYmVyPjxmb3Jl

aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZyNnZzeDkyZXQy

NTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgzMzQiPjE1PC9rZXk+PC9mb3JlaWduLWtleXM+

PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRv

cnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVmYXVsdCIgc2l6

ZT0iMTAwJSI+TGl1LCBTWVc8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+UG9vbiwgQ008L2F1dGhv

cj48YXV0aG9yPkxldW5nLCBUTDwvYXV0aG9yPjxhdXRob3I+V29uZywgQ1c8L2F1dGhvcj48YXV0

aG9yPkNoYW4sIFlMPC9hdXRob3I+PGF1dGhvcj5MZW9uZywgSFQ8L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2UtYWRtaW5pc3RlcmVkIHByb3BvZm9s

4oCTYWxmZW50YW5pbCBzZWRhdGlvbiB1c2luZyBhIHBhdGllbnQtY29udHJvbGxlZCBhbmFsZ2Vz

aWEgcHVtcCBjb21wYXJlZCB3aXRoIG9waW9pZOKAk2JlbnpvZGlhemVwaW5lIHNlZGF0aW9uIGZv

ciBvdXRwYXRpZW50IGNvbG9ub3Njb3B5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVuZG9zY29w

eTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkVuZG9z

Y29weTwvZnVsbC10aXRsZT48YWJici0xPkVuZG9zY29weTwvYWJici0xPjwvcGVyaW9kaWNhbD48

cGFnZXM+NTIyLTUyODwvcGFnZXM+PHZvbHVtZT40MTwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVy

PjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMy03MjZYPC9pc2JuPjx1

cmxzPjwvdXJscz48Y3VzdG9tMj4xOTQ0MDk1NTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJj

ZS1udW0+MTAuMTA1NS9zLTAwMjktMTIxNDcxMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9y

ZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qb29uPC9BdXRob3I+PFllYXI+MjAwNzwvWWVhcj48UmVj

TnVtPjI5PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzI1

LCAyNl08L3N0eWxlPjwvRGlzcGxheVRleHQ+PHJlY29yZD48cmVjLW51bWJlcj4yOTwvcmVjLW51

bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2cGU1ZHhhZWF2

cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MjcxNzY2Ij4yOTwva2V5PjwvZm9y

ZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9yZWYtdHlwZT48

Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQiIGZvbnQ9ImRl

ZmF1bHQiIHNpemU9IjEwMCUiPlBvb24sIENoaS1NaW5nPC9zdHlsZT48L2F1dGhvcj48YXV0aG9y

PkxldW5nLCBUYWstTHVuPC9hdXRob3I+PGF1dGhvcj5Xb25nLCBDaHVpLVdhaDwvYXV0aG9yPjxh

dXRob3I+Q2hhbiwgWXVrLUxpbmc8L2F1dGhvcj48YXV0aG9yPkxldW5nLCBUaW4tQ2h1bjwvYXV0

aG9yPjxhdXRob3I+TGVvbmcsIEhlbmctVGF0PC9hdXRob3I+PC9hdXRob3JzPjwvY29udHJpYnV0

b3JzPjx0aXRsZXM+PHRpdGxlPlNhZmV0eSBvZiBudXJzZS1hZG1pbmlzdGVyZWQgcHJvcG9mb2wg

c2VkYXRpb24gdXNpbmcgUENBIHB1bXAgZm9yIG91dHBhdGllbnQgY29sb25vc2NvcHkgaW4gQ2hp

bmVzZSBwYXRpZW50czogYSBwaWxvdCBzdHVkeTwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT48c3R5

bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5Bc2lhbiBKb3VybmFs

IG9mIDwvc3R5bGU+PHN0eWxlIGZhY2U9Im5vcm1hbCIgZm9udD0iZGVmYXVsdCIgY2hhcnNldD0i

MTYyIiBzaXplPSIxMDAlIj5TPC9zdHlsZT48c3R5bGUgZmFjZT0ibm9ybWFsIiBmb250PSJkZWZh

dWx0IiBzaXplPSIxMDAlIj51cmdlcnk8L3N0eWxlPjwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVz

PjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkFzaWFuIEpvdXJuYWwgb2Ygc3VyZ2VyeTwvZnVsbC10

aXRsZT48YWJici0xPkFzaWFuIEogU3VyZzwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+MjM5

LTI0MzwvcGFnZXM+PHZvbHVtZT4zMDwvdm9sdW1lPjxudW1iZXI+NDwvbnVtYmVyPjxkYXRlcz48

eWVhcj4yMDA3PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MTAxNS05NTg0PC9pc2JuPjx1cmxzPjwvdXJs

cz48Y3VzdG9tMj4xNzk2MjEyNSA8L2N1c3RvbTI+PGVsZWN0cm9uaWMtcmVzb3VyY2UtbnVtPjEw

LjEwMTYvUzEwMTUtOTU4NCgwOCk2MDAzMi05PC9lbGVjdHJvbmljLXJlc291cmNlLW51bT48L3Jl

Y29yZD48L0NpdGU+PENpdGU+PEF1dGhvcj5MaXU8L0F1dGhvcj48WWVhcj4yMDA5PC9ZZWFyPjxS

ZWNOdW0+MTU8L1JlY051bT48cmVjb3JkPjxyZWMtbnVtYmVyPjE1PC9yZWMtbnVtYmVyPjxmb3Jl

aWduLWtleXM+PGtleSBhcHA9IkVOIiBkYi1pZD0iOTBydzB3c3ZwZTVkeGFlYXZyNnZzeDkyZXQy

NTV4NTJwNTl2IiB0aW1lc3RhbXA9IjE1MzQwNjgzMzQiPjE1PC9rZXk+PC9mb3JlaWduLWtleXM+

PHJlZi10eXBlIG5hbWU9IkpvdXJuYWwgQXJ0aWNsZSI+MTc8L3JlZi10eXBlPjxjb250cmlidXRv

cnM+PGF1dGhvcnM+PGF1dGhvcj48c3R5bGUgZmFjZT0iYm9sZCIgZm9udD0iZGVmYXVsdCIgc2l6

ZT0iMTAwJSI+TGl1LCBTWVc8L3N0eWxlPjwvYXV0aG9yPjxhdXRob3I+UG9vbiwgQ008L2F1dGhv

cj48YXV0aG9yPkxldW5nLCBUTDwvYXV0aG9yPjxhdXRob3I+V29uZywgQ1c8L2F1dGhvcj48YXV0

aG9yPkNoYW4sIFlMPC9hdXRob3I+PGF1dGhvcj5MZW9uZywgSFQ8L2F1dGhvcj48L2F1dGhvcnM+

PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2UtYWRtaW5pc3RlcmVkIHByb3BvZm9s

4oCTYWxmZW50YW5pbCBzZWRhdGlvbiB1c2luZyBhIHBhdGllbnQtY29udHJvbGxlZCBhbmFsZ2Vz

aWEgcHVtcCBjb21wYXJlZCB3aXRoIG9waW9pZOKAk2JlbnpvZGlhemVwaW5lIHNlZGF0aW9uIGZv

ciBvdXRwYXRpZW50IGNvbG9ub3Njb3B5PC90aXRsZT48c2Vjb25kYXJ5LXRpdGxlPkVuZG9zY29w

eTwvc2Vjb25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkVuZG9z

Y29weTwvZnVsbC10aXRsZT48YWJici0xPkVuZG9zY29weTwvYWJici0xPjwvcGVyaW9kaWNhbD48

cGFnZXM+NTIyLTUyODwvcGFnZXM+PHZvbHVtZT40MTwvdm9sdW1lPjxudW1iZXI+NjwvbnVtYmVy

PjxkYXRlcz48eWVhcj4yMDA5PC95ZWFyPjwvZGF0ZXM+PGlzYm4+MDAxMy03MjZYPC9pc2JuPjx1

cmxzPjwvdXJscz48Y3VzdG9tMj4xOTQ0MDk1NTwvY3VzdG9tMj48ZWxlY3Ryb25pYy1yZXNvdXJj

ZS1udW0+MTAuMTA1NS9zLTAwMjktMTIxNDcxMTwvZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+PC9y

ZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA [25,26], when compared studies where propofol alone usedPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaXBlPC9BdXRob3I+PFllYXI+MjAwMjwvWWVhcj48UmVj

TnVtPjM1PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzE5

LCAyNywgMjhdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MzU8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4

YWVhdnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDQ1MDkwOCI+MzU8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250

PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5TaXBlLCBCcmlhbiBXPC9zdHlsZT48L2F1dGhvcj48YXV0

aG9yPlJleCwgRG91Z2xhcyBLPC9hdXRob3I+PGF1dGhvcj5MYXRpbm92aWNoLCBEYW5pZWxsZTwv

YXV0aG9yPjxhdXRob3I+T3ZlcmxleSwgQ2hyaXM8L2F1dGhvcj48YXV0aG9yPktpbnNlciwgS2Fy

ZW48L2F1dGhvcj48YXV0aG9yPkJyYXRjaGVyLCBMaXNhPC9hdXRob3I+PGF1dGhvcj5LYXJla2Vu

LCBEYXZpZDwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Q

cm9wb2ZvbCB2ZXJzdXMgbWlkYXpvbGFtL21lcGVyaWRpbmUgZm9yIG91dHBhdGllbnQgY29sb25v

c2NvcHk6IGFkbWluaXN0cmF0aW9uIGJ5IG51cnNlcyBzdXBlcnZpc2VkIGJ5IGVuZG9zY29waXN0

czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5HYXN0cm9pbnRlc3RpbmFsIGVuZG9zY29weTwvc2Vj

b25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkdhc3Ryb2ludGVz

dGluYWwgZW5kb3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+R2FzdHJvaW50ZXN0IEVuZG9zYzwv

YWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+ODE1LTgyNTwvcGFnZXM+PHZvbHVtZT41NTwvdm9s

dW1lPjxudW1iZXI+NzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAyPC95ZWFyPjwvZGF0ZXM+PGlz

Ym4+MDAxNi01MTA3PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xMjAyNDEzNDwvY3VzdG9t

Mj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA2Ny9tZ2UuMjAwMi4xMjQ2MzY8L2VsZWN0

cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkvDvGxsaW5n

PC9BdXRob3I+PFllYXI+MjAwMzwvWWVhcj48UmVjTnVtPjM2PC9SZWNOdW0+PHJlY29yZD48cmVj

LW51bWJlcj4zNjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0NDUx

MDA1Ij4zNjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZh

Y2U9ImJvbGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPkvDvGxsaW5nLCBEPC9zdHlsZT48

L2F1dGhvcj48YXV0aG9yPlJvdGhlbmLDvGhsZXIsIFI8L2F1dGhvcj48YXV0aG9yPkluYXVlbiwg

VzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5TYWZldHkg

b2Ygbm9uYW5lc3RoZXRpc3Qgc2VkYXRpb24gd2l0aCBwcm9wb2ZvbCBmb3Igb3V0cGF0aWVudCBj

b2xvbm9zY29weSBhbmQgZXNvcGhhZ29nYXN0cm9kdW9kZW5vc2NvcHk8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+RW5kb3Njb3B5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+RW5kb3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3Njb3B5PC9hYmJy

LTE+PC9wZXJpb2RpY2FsPjxwYWdlcz42NzktNjgyPC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+

PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4w

MDEzLTcyNlg8L2lzYm4+PHVybHM+PC91cmxzPjxjdXN0b20yPjEyOTI5MDY0PC9jdXN0b20yPjxl

bGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDU1L3MtMjAwMy00MTUxODwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+V2Fsa2VyPC9BdXRob3I+

PFllYXI+MjAwMzwvWWVhcj48UmVjTnVtPjEwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4x

MDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2

cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4MzA0Ij4xMDwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQi

IGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPldhbGtlciwgSm9obiBBPC9zdHlsZT48L2F1dGhv

cj48YXV0aG9yPk1jSW50eXJlLCBSb2JlcnQgRDwvYXV0aG9yPjxhdXRob3I+U2NobGVpbml0eiwg

UGF1bCBGPC9hdXRob3I+PGF1dGhvcj5KYWNvYnNvbiwgS3JpcyBOPC9hdXRob3I+PGF1dGhvcj5I

YXVsaywgQW50aG9ueSBBPC9hdXRob3I+PGF1dGhvcj5BZGVzbWFuLCBQZXRlcjwvYXV0aG9yPjxh

dXRob3I+VG9sbGVzb24sIFNoZWxsZXk8L2F1dGhvcj48YXV0aG9yPlBhcmVudCwgUm9ieW48L2F1

dGhvcj48YXV0aG9yPkRvbm5lbGx5LCBSb3NpZTwvYXV0aG9yPjxhdXRob3I+UmV4LCBEb3VnbGFz

IEs8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2Ut

YWRtaW5pc3RlcmVkIHByb3BvZm9sIHNlZGF0aW9uIHdpdGhvdXQgYW5lc3RoZXNpYSBzcGVjaWFs

aXN0cyBpbiA5MTUyIGVuZG9zY29waWMgY2FzZXMgaW4gYW4gYW1idWxhdG9yeSBzdXJnZXJ5IGNl

bnRlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0

cm9lbnRlcm9sb2d5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+VGhlIEFtZXJpY2FuIGpvdXJuYWwgb2YgZ2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRs

ZT48YWJici0xPkFtIEogR2FzdHJvZW50ZXJvbDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+

MTc0NC0xNzUwPC9wYWdlcz48dm9sdW1lPjk4PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRh

dGVzPjx5ZWFyPjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4wMDAyLTkyNzA8L2lzYm4+PHVybHM+

PC91cmxzPjxjdXN0b20yPjEyOTA3MzI4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51

bT4xMC4xMTExL2ouMTU3Mi0wMjQxLjIwMDMuMDc2MDUueDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u

dW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5TaXBlPC9BdXRob3I+PFllYXI+MjAwMjwvWWVhcj48UmVj

TnVtPjM1PC9SZWNOdW0+PERpc3BsYXlUZXh0PjxzdHlsZSBmYWNlPSJzdXBlcnNjcmlwdCI+WzE5

LCAyNywgMjhdPC9zdHlsZT48L0Rpc3BsYXlUZXh0PjxyZWNvcmQ+PHJlYy1udW1iZXI+MzU8L3Jl

Yy1udW1iZXI+PGZvcmVpZ24ta2V5cz48a2V5IGFwcD0iRU4iIGRiLWlkPSI5MHJ3MHdzdnBlNWR4

YWVhdnI2dnN4OTJldDI1NXg1MnA1OXYiIHRpbWVzdGFtcD0iMTUzNDQ1MDkwOCI+MzU8L2tleT48

L2ZvcmVpZ24ta2V5cz48cmVmLXR5cGUgbmFtZT0iSm91cm5hbCBBcnRpY2xlIj4xNzwvcmVmLXR5

cGU+PGNvbnRyaWJ1dG9ycz48YXV0aG9ycz48YXV0aG9yPjxzdHlsZSBmYWNlPSJib2xkIiBmb250

PSJkZWZhdWx0IiBzaXplPSIxMDAlIj5TaXBlLCBCcmlhbiBXPC9zdHlsZT48L2F1dGhvcj48YXV0

aG9yPlJleCwgRG91Z2xhcyBLPC9hdXRob3I+PGF1dGhvcj5MYXRpbm92aWNoLCBEYW5pZWxsZTwv

YXV0aG9yPjxhdXRob3I+T3ZlcmxleSwgQ2hyaXM8L2F1dGhvcj48YXV0aG9yPktpbnNlciwgS2Fy

ZW48L2F1dGhvcj48YXV0aG9yPkJyYXRjaGVyLCBMaXNhPC9hdXRob3I+PGF1dGhvcj5LYXJla2Vu

LCBEYXZpZDwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5Q

cm9wb2ZvbCB2ZXJzdXMgbWlkYXpvbGFtL21lcGVyaWRpbmUgZm9yIG91dHBhdGllbnQgY29sb25v

c2NvcHk6IGFkbWluaXN0cmF0aW9uIGJ5IG51cnNlcyBzdXBlcnZpc2VkIGJ5IGVuZG9zY29waXN0

czwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5HYXN0cm9pbnRlc3RpbmFsIGVuZG9zY29weTwvc2Vj

b25kYXJ5LXRpdGxlPjwvdGl0bGVzPjxwZXJpb2RpY2FsPjxmdWxsLXRpdGxlPkdhc3Ryb2ludGVz

dGluYWwgZW5kb3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+R2FzdHJvaW50ZXN0IEVuZG9zYzwv

YWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+ODE1LTgyNTwvcGFnZXM+PHZvbHVtZT41NTwvdm9s

dW1lPjxudW1iZXI+NzwvbnVtYmVyPjxkYXRlcz48eWVhcj4yMDAyPC95ZWFyPjwvZGF0ZXM+PGlz

Ym4+MDAxNi01MTA3PC9pc2JuPjx1cmxzPjwvdXJscz48Y3VzdG9tMj4xMjAyNDEzNDwvY3VzdG9t

Mj48ZWxlY3Ryb25pYy1yZXNvdXJjZS1udW0+MTAuMTA2Ny9tZ2UuMjAwMi4xMjQ2MzY8L2VsZWN0

cm9uaWMtcmVzb3VyY2UtbnVtPjwvcmVjb3JkPjwvQ2l0ZT48Q2l0ZT48QXV0aG9yPkvDvGxsaW5n

PC9BdXRob3I+PFllYXI+MjAwMzwvWWVhcj48UmVjTnVtPjM2PC9SZWNOdW0+PHJlY29yZD48cmVj

LW51bWJlcj4zNjwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9

Ijkwcncwd3N2cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0NDUx

MDA1Ij4zNjwva2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGlj

bGUiPjE3PC9yZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZh

Y2U9ImJvbGQiIGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPkvDvGxsaW5nLCBEPC9zdHlsZT48

L2F1dGhvcj48YXV0aG9yPlJvdGhlbmLDvGhsZXIsIFI8L2F1dGhvcj48YXV0aG9yPkluYXVlbiwg

VzwvYXV0aG9yPjwvYXV0aG9ycz48L2NvbnRyaWJ1dG9ycz48dGl0bGVzPjx0aXRsZT5TYWZldHkg

b2Ygbm9uYW5lc3RoZXRpc3Qgc2VkYXRpb24gd2l0aCBwcm9wb2ZvbCBmb3Igb3V0cGF0aWVudCBj

b2xvbm9zY29weSBhbmQgZXNvcGhhZ29nYXN0cm9kdW9kZW5vc2NvcHk8L3RpdGxlPjxzZWNvbmRh

cnktdGl0bGU+RW5kb3Njb3B5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+

PGZ1bGwtdGl0bGU+RW5kb3Njb3B5PC9mdWxsLXRpdGxlPjxhYmJyLTE+RW5kb3Njb3B5PC9hYmJy

LTE+PC9wZXJpb2RpY2FsPjxwYWdlcz42NzktNjgyPC9wYWdlcz48dm9sdW1lPjM1PC92b2x1bWU+

PG51bWJlcj44PC9udW1iZXI+PGRhdGVzPjx5ZWFyPjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4w

MDEzLTcyNlg8L2lzYm4+PHVybHM+PC91cmxzPjxjdXN0b20yPjEyOTI5MDY0PC9jdXN0b20yPjxl

bGVjdHJvbmljLXJlc291cmNlLW51bT4xMC4xMDU1L3MtMjAwMy00MTUxODwvZWxlY3Ryb25pYy1y

ZXNvdXJjZS1udW0+PC9yZWNvcmQ+PC9DaXRlPjxDaXRlPjxBdXRob3I+V2Fsa2VyPC9BdXRob3I+

PFllYXI+MjAwMzwvWWVhcj48UmVjTnVtPjEwPC9SZWNOdW0+PHJlY29yZD48cmVjLW51bWJlcj4x

MDwvcmVjLW51bWJlcj48Zm9yZWlnbi1rZXlzPjxrZXkgYXBwPSJFTiIgZGItaWQ9Ijkwcncwd3N2

cGU1ZHhhZWF2cjZ2c3g5MmV0MjU1eDUycDU5diIgdGltZXN0YW1wPSIxNTM0MDY4MzA0Ij4xMDwv

a2V5PjwvZm9yZWlnbi1rZXlzPjxyZWYtdHlwZSBuYW1lPSJKb3VybmFsIEFydGljbGUiPjE3PC9y

ZWYtdHlwZT48Y29udHJpYnV0b3JzPjxhdXRob3JzPjxhdXRob3I+PHN0eWxlIGZhY2U9ImJvbGQi

IGZvbnQ9ImRlZmF1bHQiIHNpemU9IjEwMCUiPldhbGtlciwgSm9obiBBPC9zdHlsZT48L2F1dGhv

cj48YXV0aG9yPk1jSW50eXJlLCBSb2JlcnQgRDwvYXV0aG9yPjxhdXRob3I+U2NobGVpbml0eiwg

UGF1bCBGPC9hdXRob3I+PGF1dGhvcj5KYWNvYnNvbiwgS3JpcyBOPC9hdXRob3I+PGF1dGhvcj5I

YXVsaywgQW50aG9ueSBBPC9hdXRob3I+PGF1dGhvcj5BZGVzbWFuLCBQZXRlcjwvYXV0aG9yPjxh

dXRob3I+VG9sbGVzb24sIFNoZWxsZXk8L2F1dGhvcj48YXV0aG9yPlBhcmVudCwgUm9ieW48L2F1

dGhvcj48YXV0aG9yPkRvbm5lbGx5LCBSb3NpZTwvYXV0aG9yPjxhdXRob3I+UmV4LCBEb3VnbGFz

IEs8L2F1dGhvcj48L2F1dGhvcnM+PC9jb250cmlidXRvcnM+PHRpdGxlcz48dGl0bGU+TnVyc2Ut

YWRtaW5pc3RlcmVkIHByb3BvZm9sIHNlZGF0aW9uIHdpdGhvdXQgYW5lc3RoZXNpYSBzcGVjaWFs

aXN0cyBpbiA5MTUyIGVuZG9zY29waWMgY2FzZXMgaW4gYW4gYW1idWxhdG9yeSBzdXJnZXJ5IGNl

bnRlcjwvdGl0bGU+PHNlY29uZGFyeS10aXRsZT5UaGUgQW1lcmljYW4gam91cm5hbCBvZiBnYXN0

cm9lbnRlcm9sb2d5PC9zZWNvbmRhcnktdGl0bGU+PC90aXRsZXM+PHBlcmlvZGljYWw+PGZ1bGwt

dGl0bGU+VGhlIEFtZXJpY2FuIGpvdXJuYWwgb2YgZ2FzdHJvZW50ZXJvbG9neTwvZnVsbC10aXRs

ZT48YWJici0xPkFtIEogR2FzdHJvZW50ZXJvbDwvYWJici0xPjwvcGVyaW9kaWNhbD48cGFnZXM+

MTc0NC0xNzUwPC9wYWdlcz48dm9sdW1lPjk4PC92b2x1bWU+PG51bWJlcj44PC9udW1iZXI+PGRh

dGVzPjx5ZWFyPjIwMDM8L3llYXI+PC9kYXRlcz48aXNibj4wMDAyLTkyNzA8L2lzYm4+PHVybHM+

PC91cmxzPjxjdXN0b20yPjEyOTA3MzI4PC9jdXN0b20yPjxlbGVjdHJvbmljLXJlc291cmNlLW51

bT4xMC4xMTExL2ouMTU3Mi0wMjQxLjIwMDMuMDc2MDUueDwvZWxlY3Ryb25pYy1yZXNvdXJjZS1u

dW0+PC9yZWNvcmQ+PC9DaXRlPjwvRW5kTm90ZT5=

ADDIN EN.CITE.DATA [19,27,28]. In our study, the consumption of propofol decreased as expected by the addition of ketamine, which provides analgesia and dissociative anaesthesia, and midazolam, which has amnesic and sedative properties, to the sedation protocol. The total amount of propofol used in both groups was significantly lower than the previous studies in which the SSEN method was applied. (The consumption of propofol in the SSEN group and SSA group was 83.0 ± 57.1, 59.7 ± 17.5 respectively). In our study, propofol consumption was significantly higher in the SSEN group. The reason for this significant difference in propofol consumption was thought to be the longer duration of the operations in the SSEN group. The duration of the procedure is significantly higher in the SSEN group than in the SSA group. When interviewed with the endoscopist, it was stated that two sedation methods did not affect the difficulty of operation. Therefore, this difference may be due to the small number of patients or the fact that the procedure was performed by two different endoscopists.Cardiovascular and respiratory depression can be observed during sedation. Our most important goal in colonoscopy sedation is to ensure the safety of patients as well as comfort. For this reason, we aimed to have less cardiovascular and respiratory side effects by using lower doses of propofol with a combined sedation protocol. There is no analgesic activity of propofol. However, it has a synergistic effect when used with analgesic agents ADDIN EN.CITE <EndNote><Cite><Author>Horn</Author><Year>2004</Year><RecNum>13</RecNum><DisplayText><style face="superscript">[29]</style></DisplayText><record><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068322">13</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Horn, Ed</style></author><author>Nesbit, Suzanne Amato</author></authors></contributors><titles><title>Pharmacology and pharmacokinetics of sedatives and analgesics</title><secondary-title>Gastrointestinal endoscopy clinics of North America</secondary-title></titles><periodical><full-title>Gastrointestinal endoscopy clinics of North America</full-title><abbr-1>Gastrointest Endosc Clin N Am</abbr-1></periodical><pages>247-268</pages><volume>14</volume><number>2</number><dates><year>2004</year></dates><isbn>1052-5157</isbn><urls></urls><custom2>15121142</custom2><electronic-resource-num>10.1016/j.giec.2004.01.001</electronic-resource-num></record></Cite></EndNote>[29]. In a study by Hsu et al ADDIN EN.CITE <EndNote><Cite><Author>Hsu</Author><Year>2015</Year><RecNum>14</RecNum><DisplayText><style face="superscript">[30]</style></DisplayText><record><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068330">14</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Hsu, Chiung-Dan</style></author><author>Huang, Jui-Mei</author><author>Chuang, Ya-Ping</author><author>Wei, Hua-Yi</author><author>Su, Yu-Chung</author><author>Wu, Jeng-Yih</author><author>Wang, Wen-Ming</author><author>Hsu, Hung-Te</author><author>Huang, Hui-Fang</author><author>Lu, I-Cheng</author></authors></contributors><titles><title>Propofol target-controlled infusion for sedated gastrointestinal endoscopy: A comparison of propofol alone versus propofol–fentanyl–midazolam</title><secondary-title>The Kaohsiung journal of medical sciences</secondary-title></titles><periodical><full-title>The Kaohsiung journal of medical sciences</full-title><abbr-1>Kaohsiung J Med Sci</abbr-1></periodical><pages>580-584</pages><volume>31</volume><number>11</number><dates><year>2015</year></dates><isbn>1607-551X</isbn><urls></urls><custom2>26678938</custom2><electronic-resource-num>10.1016/j.kjms.2015.09.004</electronic-resource-num></record></Cite></EndNote>[30], one group of patients who underwent gastrointestinal endoscopy were performed sedation with propofol alone and the other group with propofol-midazolam-fentanyl combination. As a result, it was stated that propofol alone group had higher total propofol consumption and incidence of hypotension; the recovery time of this group was also longer. Some clinicians avoid propofol administration without anaesthetist because of the absence of propofol antidote in a possible cardiopulmonary complication. However, the short duration of the propofol balances this negative feature. In our study, no serious long-term side effects were observed in any of the patients. All of the cardiopulmonary side effects that occurred were ended shortly (less than 30 s) without the need for intervention. Of course, a much safer SSEN application can be achieved by the fact that the patient is closely followed up with monitored and sedation practitioners is trained in cardiopulmonary resuscitation. Only low-risk patients with ASA I-II were included in our study, but Heuss et al ADDIN EN.CITE <EndNote><Cite><Author>Heuss</Author><Year>2003</Year><RecNum>30</RecNum><DisplayText><style face="superscript">[31]</style></DisplayText><record><rec-number>30</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534272041">30</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Heuss, Ludwig T</style></author><author>Schnieper, Patrizia</author><author>Drewe, Juergen</author><author>Pflimlin, Eric</author><author>Beglinger, Christoph</author></authors></contributors><titles><title>Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients–a prospective, controlled study</title><secondary-title>The American journal of gastroenterology</secondary-title></titles><periodical><full-title>The American journal of gastroenterology</full-title><abbr-1>Am J Gastroenterol</abbr-1></periodical><pages>1751-1757</pages><volume>98</volume><number>8</number><dates><year>2003</year></dates><isbn>0002-9270</isbn><urls></urls><custom2>12907329</custom2><electronic-resource-num>10.1111/j.1572-0241.2003.07596.x</electronic-resource-num></record></Cite></EndNote>[31] showed that propofol can be safely applied in gastrointestinal endoscopy even in high-risk patients. They stated that these patients should be more closely monitored in terms of desaturation and propofol use in these patients would be appropriate at doses of 10%-20% lower than in ASA I-II plications such as emergence reactions, hypertension, tachycardia, visual hallucinations, vivid dreams, tonic-clonic movements, diplopia, nystagmus, increased intracranial pressure, and increased intraocular pressure are among the complications associated with ketamine ADDIN EN.CITE <EndNote><Cite><RecNum>41</RecNum><DisplayText><style face="superscript">[32]</style></DisplayText><record><rec-number>41</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1541699103">41</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors></contributors><titles><title>ketamine (Rx)</title></titles><number><style face="normal" font="default" charset="162" size="100%">8 Nov 2018</style></number><dates></dates><urls><related-urls><url>;[32]. Even 24 h after application, side effects such as severe confusion, hallucinations, unusual thoughts, or extreme fear can be seen ADDIN EN.CITE <EndNote><Cite><RecNum>42</RecNum><DisplayText><style face="superscript">[33]</style></DisplayText><record><rec-number>42</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1541699524">42</key></foreign-keys><ref-type name="Web Page">12</ref-type><contributors><secondary-authors><author>Medical Editor: John P. Cunha, DO, FACOEP</author></secondary-authors></contributors><titles><title>Ketamine Hydrochloride(Ketamine HCl) side effects drug center</title></titles><number><style face="normal" font="default" charset="162" size="100%">8 Nov 2018</style></number><dates></dates><urls><related-urls><url>;[33]. In our study, nausea, vomiting, and agitation that were the possible side effects due to ketamine added to the sedation protocol were not observed in any of the patients in both groups ADDIN EN.CITE <EndNote><Cite><Author>Shah</Author><Year>2011</Year><RecNum>32</RecNum><DisplayText><style face="superscript">[34]</style></DisplayText><record><rec-number>32</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534361308">32</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Shah, Amit</style></author><author>Mosdossy, Gregory</author><author>McLeod, Shelley</author><author>Lehnhardt, Kris</author><author>Peddle, Michael</author><author>Rieder, Michael</author></authors></contributors><titles><title>A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children</title><secondary-title>Annals of emergency medicine</secondary-title></titles><periodical><full-title>Annals of emergency medicine</full-title><abbr-1>Ann Emerg Med</abbr-1></periodical><pages>425-433. e2</pages><volume>57</volume><number>5</number><dates><year>2011</year></dates><isbn>0196-0644</isbn><urls></urls><custom2>20947210</custom2><electronic-resource-num>10.1016/j.annemergmed.2010.08.032</electronic-resource-num></record></Cite></EndNote>[34]. The use of ketamine in combination with low doses of propofol and midazolam may have reduced the incidence of side effects. Guit et al ADDIN EN.CITE <EndNote><Cite><Author>Guit</Author><Year>1991</Year><RecNum>31</RecNum><DisplayText><style face="superscript">[35]</style></DisplayText><record><rec-number>31</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534352243">31</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Guit, JBM</style></author><author>Koning, HM</author><author>Coster, ML</author><author>Niemeijer, RPE</author><author>Mackie, DP</author></authors></contributors><titles><title>Ketamine as analgesic for total intravenous anaesthesia with propofol</title><secondary-title>Anaesthesia</secondary-title></titles><periodical><full-title>Anaesthesia</full-title><abbr-1>Anaesthesia</abbr-1></periodical><pages>24-27</pages><volume>46</volume><number>1</number><dates><year>1991</year></dates><isbn>0003-2409</isbn><urls></urls><custom2>1996747</custom2><electronic-resource-num>10.1111/j.1365-2044.1991.tb09308.x </electronic-resource-num></record></Cite></EndNote>[35] showed that ketamine-related side effects are reduced, when ketamine is combined with propofol.In our study, several questions were asked to patients in order to determine patient satisfaction, which is one of our primary goals. There was no significant difference between the groups in terms of patient satisfaction score and re-preference for the same sedation method in case of re-endoscopy. All of the patients in the SSEN group and 93.3% of the patients in the SSA group stated that they would re-prefer the same sedation method in case of re-endoscopy. Poon et al. reported that 92% of patients would re-prefer the same sedation method in a new endoscopy procedure ADDIN EN.CITE <EndNote><Cite><Author>Poon</Author><Year>2007</Year><RecNum>29</RecNum><DisplayText><style face="superscript">[25]</style></DisplayText><record><rec-number>29</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534271766">29</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Poon, Chi-Ming</style></author><author>Leung, Tak-Lun</author><author>Wong, Chui-Wah</author><author>Chan, Yuk-Ling</author><author>Leung, Tin-Chun</author><author>Leong, Heng-Tat</author></authors></contributors><titles><title>Safety of nurse-administered propofol sedation using PCA pump for outpatient colonoscopy in Chinese patients: a pilot study</title><secondary-title><style face="normal" font="default" size="100%">Asian Journal of </style><style face="normal" font="default" charset="162" size="100%">S</style><style face="normal" font="default" size="100%">urgery</style></secondary-title></titles><periodical><full-title>Asian Journal of surgery</full-title><abbr-1>Asian J Surg</abbr-1></periodical><pages>239-243</pages><volume>30</volume><number>4</number><dates><year>2007</year></dates><isbn>1015-9584</isbn><urls></urls><custom2>17962125 </custom2><electronic-resource-num>10.1016/S1015-9584(08)60032-9</electronic-resource-num></record></Cite></EndNote>[25]. The result of our study is similar to the results of this study. One of the questions asked to evaluate patient satisfaction is whether the patient remembered the operation. There was no significant difference between the groups in terms of recall of the procedure. Adequate sedation and pain control provides a comfortable and successful colonoscopy. When the pain status of the patients was questioned in our study, 96.6% of the patients in the SSEN group and 86.6% of the patients in the SSA group were found to have a VAS below 1. Liu et al ADDIN EN.CITE <EndNote><Cite><Author>Liu</Author><Year>2009</Year><RecNum>15</RecNum><DisplayText><style face="superscript">[26]</style></DisplayText><record><rec-number>15</rec-number><foreign-keys><key app="EN" db-id="90rw0wsvpe5dxaeavr6vsx92et255x52p59v" timestamp="1534068334">15</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="bold" font="default" size="100%">Liu, SYW</style></author><author>Poon, CM</author><author>Leung, TL</author><author>Wong, CW</author><author>Chan, YL</author><author>Leong, HT</author></authors></contributors><titles><title>Nurse-administered propofol–alfentanil sedation using a patient-controlled analgesia pump compared with opioid–benzodiazepine sedation for outpatient colonoscopy</title><secondary-title>Endoscopy</secondary-title></titles><periodical><full-title>Endoscopy</full-title><abbr-1>Endoscopy</abbr-1></periodical><pages>522-528</pages><volume>41</volume><number>6</number><dates><year>2009</year></dates><isbn>0013-726X</isbn><urls></urls><custom2>19440955</custom2><electronic-resource-num>10.1055/s-0029-1214711</electronic-resource-num></record></Cite></EndNote>[26] also compared the two sedation methods under the supervision of an anaesthetist/nurse using PCA pump. In their study, there was no significant difference between the groups in terms of patient satisfaction and VAS values.In conclusion, this study demonstrated that the combination of midazolam-ketamine-propofol could be performed under the supervision of both anaesthetist and endoscopy nurse with a PCA device in colonoscopy sedation of low-risk (ASA I-II) patients with similar side effects. There is a need for further studies with ASA III-IV patients and also with more patients.A small sample size ASA I-II patients with low cardiovascular risk were included in the study. The expected incidence of adverse events is less than 0.01%, and studies with a small sample size may reduce this rate.Article HighlightsResearch backgroundSedation is performed in many centers during the colonoscopy procedure. However, since there are a limited number of anesthesiologists, there are centers where colonoscopy is performed without sedation. In the literature, there are several studies in which colonoscopy sedation is performed without anesthesia personnel. In this study, we aim to evaluate the patient satisfaction and the side effects of colonoscopy sedation performed by endoscopy nurse with patient-controlled analgesia (PCA) pump.Research motivationIn studies where colonoscopy sedation was performed under the supervision of a nurse, propofol is often used alone or in combination with agents such as fentanyl, meperidine or midazolam. Ketamine, which protects spontaneous breathing and protective airway reflexes by providing dissociative anesthesia, was not used in colonoscopy in adult patients. In our study, we wanted to determine the advantages and disadvantages of ketamine in combination with propofol and midazolam without anesthesia personnel in colonoscopy.Research objectivesIt is aimed to perform ketamine-midazolam-propofol sedation with minimum side effects and to obtain the best patient satisfaction under the supervision of a nurse in low risk patients in colonoscopy. Individual dose errors were tried to be minimized by using PCA pump.Research methods60 American Statistical Association (ASA) I-II patients who underwent colonoscopy were included in the study. Patients were randomly divided into two groups [sedation under the supervision of anaesthetist (SSA) and sedation under the supervision of endoscopy nurse (SSEN)]. Both groups were initially administered 1 mg of midazolam, 50 mg of ketamine, and 30-50 mg of propofol. Then the required dose of propofol in SSA group was determined and administered by anesthesiologist. In SSEN group, the continuation of sedation was carried out by the nurse with PCA pump. Data such as patient satisfaction, incidence of side effects, total drug consumption, and duration of procedure were recorded and differences among the groups were evaluated.Research resultsThere were no statistically significant differences (P ? 0.05) between the two groups in terms of patient satisfaction, the rate of re-preference for the same method in case of re-endoscopy, and the side effects. The total propofol consumption in the SSEN group was significantly higher (P < 0.05), whereas the systolic and diastolic pressure values were found to be significantly lower (P < 0.05) at 5 min, and after 8 min. Reaching the cecum and total procedure time were significantly longer (P < 0.05) in the SSEN group. No significant prolonged side effects were observed in both groups.Research conclusionsIn ASA I-II patients, sedation under the supervision of nurses with PCA pump in colonoscopy has similar side effects and patient satisfaction levels as sedation under SSA.Research perspectivesThere is a need for further studies with ASA III-IV patients and also with more patients.ACKNOWLEDGEMENTWe would like to sincerely thank general surgery specialists, Dr. Abdullah Haluk ?irin and Dr. Muhammed Emin Yenen, for their cooperation.REFERENCES1 Ghanouni A, Plumb A, Hewitson P, Nickerson C, Rees CJ, von Wagner C. Patients' experience of colonoscopy in the English Bowel Cancer Screening Programme. Endoscopy 2016; 48: 232-240 [PMID: 26841268 DOI: 10.1055/s-0042-100613]2 Ferreira AO, Cravo M. Sedation in gastrointestinal endoscopy: Where are we at in 2014? World J Gastrointest Endosc 2015; 7: 102-109 [PMID: 25685266 DOI: 10.4253/wjge.v7.i2.102]3 Lin OS. Sedation for routine gastrointestinal endoscopic procedures: a review on efficacy, safety, efficiency, cost and satisfaction. Intest Res 2017; 15: 456-466 [PMID: 29142513 DOI: 10.5217/ir.2017.15.4.456]4 Faulx AL, Vela S, Das A, Cooper G, Sivak MV, Isenberg G, Chak A. The changing landscape of practice patterns regarding unsedated endoscopy and propofol use: a national Web survey. Gastrointest Endosc 2005; 62: 9-15 [PMID: 15990813 DOI: 10.1016/S0016-5107(05)00518-3]5 Türk H?, Aydo?mu? M, ?nsal O, K?ksal HM, A?ik ME, Oba S. Sedation-analgesia in elective colonoscopy: propofol-fentanyl versus propofol-alfentanil. Braz J Anesthesiol 2013; 63: 352-357 [PMID: 23931250 DOI: 10.1016/j.bjan.2012.07.006]6 Joo HS, Perks WJ, Kataoka MT, Errett L, Pace K, Honey RJ. A comparison of patient-controlled sedation using either remifentanil or remifentanil-propofol for shock wave lithotripsy. Anesth Analg 2001; 93: 1227-1232 [PMID: 11682403 DOI: 10.1097/00000539-200111000-00037]7 Alletag MJ, Auerbach MA, Baum CR. Ketamine, propofol, and ketofol use for pediatric sedation. Pediatr Emerg Care 2012; 28: 1391-5; quiz 1396-8 [PMID: 23222112 DOI: 10.1097/PEC.0b013e318276fde2]8 Green SM, Krauss B. Clinical practice guideline for emergency department ketamine dissociative sedation in children. Ann Emerg Med 2004; 44: 460-471 [PMID: 15520705 DOI: 10.1016/S0196064404006365]9 Strayer RJ, Nelson LS. Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med 2008; 26: 985-1028 [PMID: 19091264 DOI: 10.1016/j.ajem.2007.12.005]10 Rex DK. Effect of the Centers for Medicare &amp; Medicaid Services policy about deep sedation on use of propofol. Ann Intern Med 2011; 154: 622-626 [PMID: 21536938 DOI: 10.7326/0003-4819-154-9-201105030-00007]11 Aisenberg J, Cohen LB, Piorkowski JD Jr. Propofol use under the direction of trained gastroenterologists: an analysis of the medicolegal implications. Am J Gastroenterol 2007; 102: 707-713 [PMID: 17397402 DOI: 10.1111/j.1572-0241.2006.00955.x]12 Lienhart A, Carli P, Marty J, Pourriat J. Digestive endoscopies: who does what? Proceedings of the Annales francaises d'anesthesie et de reanimation 2002: 343-34613 Crepeau T, Poincloux L, Bonny C, Lighetto S, Jaffeux P, Artigue F, Walleckx P, Bazin JE, Dapoigny M, Bommelaer G. Significance of patient-controlled sedation during colonoscopy. Results from a prospective randomized controlled study. Gastroenterol Clin Biol 2005; 29: 1090-1096 [PMID: 16505753 DOI: 10.1016/S0399-8320(05)82172-4]14 American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists.. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002; 96: 1004-1017 [PMID: 11964611 DOI: 10.1097/00000542-200204000-00031]15 Sieg A; bng-Study-Group, Beck S, Scholl SG, Heil FJ, Gotthardt DN, Stremmel W, Rex DK, Friedrich K. Safety analysis of endoscopist-directed propofol sedation: a prospective, national multicenter study of 24?441 patients in German outpatient practices. J Gastroenterol Hepatol 2014; 29: 517-523 [PMID: 24716213 DOI: 10.1111/jgh.12458]16 Rex DK, Deenadayalu VP, Eid E, Imperiale TF, Walker JA, Sandhu K, Clarke AC, Hillman LC, Horiuchi A, Cohen LB, Heuss LT, Peter S, Beglinger C, Sinnott JA, Welton T, Rofail M, Subei I, Sleven R, Jordan P, Goff J, Gerstenberger PD, Munnings H, Tagle M, Sipe BW, Wehrmann T, Di Palma JA, Occhipinti KE, Barbi E, Riphaus A, Amann ST, Tohda G, McClellan T, Thueson C, Morse J, Meah N. Endoscopist-directed administration of propofol: a worldwide safety experience. Gastroenterology 2009; 137: 1229-37; quiz 1518-9 [PMID: 19549528 DOI: 10.1053/j.gastro.2009.06.042]17 Rex DK, Heuss LT, Walker JA, Qi R. Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy. Gastroenterology 2005; 129: 1384-1391 [PMID: 16285939 DOI: 10.1053/j.gastro.2005.08.014]18 Sathananthan D, Young E, Nind G, George B, Ashby A, Drummond S, Redel K, Green N, Singh R. Assessing the safety of physician-directed nurse-administered propofol sedation in low-risk patients undergoing endoscopy and colonoscopy. Endosc Int Open 2017; 5: E110-E115 [PMID: 28210707 DOI: 10.1055/s-0042-121667]19 Walker JA, McIntyre RD, Schleinitz PF, Jacobson KN, Haulk AA, Adesman P, Tolleson S, Parent R, Donnelly R, Rex DK. Nurse-administered propofol sedation without anesthesia specialists in 9152 endoscopic cases in an ambulatory surgery center. Am J Gastroenterol 2003; 98: 1744-1750 [PMID: 12907328 DOI: 10.1111/j.1572-0241.2003.07605.x]20 Dumonceau JM, Riphaus A, Beilenhoff U, Vilmann P, Hornslet P, Aparicio JR, Dinis-Ribeiro M, Giostra E, Ortmann M, Knape JT, Ladas S, Paspatis G, Ponsioen CY, Racz I, Wehrmann T, Walder B. European curriculum for sedation training in gastrointestinal endoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA). Endoscopy 2013; 45: 496-504 [PMID: 23702777 DOI: 10.1055/s-0033-1344142]21 Sultan SS. Patient-controlled sedation with propofol/remifentanil versus propofol/alfentanil for patients undergoing outpatient colonoscopy, a randomized, controlled double-blind study. Saudi J Anaesth 2014; 8: S36-S40 [PMID: 25538518 DOI: 10.4103/1658-354X.144068]22 Sieg A. Propofol sedation in outpatient colonoscopy by trained practice nurses supervised by the gastroenterologist: a prospective evaluation of over 3000 cases. Z Gastroenterol 2007; 45: 697-701 [PMID: 17701858 DOI: 10.1055/s-2007-963349]23 Tohda G, Higashi S, Wakahara S, Morikawa M, Sakumoto H, Kane T. Propofol sedation during endoscopic procedures: safe and effective administration by registered nurses supervised by endoscopists. Endoscopy 2006; 38: 360-367 [PMID: 16680635 DOI: 10.1055/s-2005-921192]24 Heuss LT, Drewe J, Schnieper P, Tapparelli CB, Pflimlin E, Beglinger C. Patient-controlled versus nurse-administered sedation with propofol during colonoscopy. A prospective randomized trial. Am J Gastroenterol 2004; 99: 511-518 [PMID: 15056094 DOI: 10.1111/j.1572-0241.2004.04088.x]25 Poon CM, Leung TL, Wong CW, Chan YL, Leung TC, Leong HT. Safety of nurse-administered propofol sedation using PCA pump for outpatient colonoscopy in Chinese patients: a pilot study. Asian J Surg 2007; 30: 239-243 [PMID: 17962125 DOI: 10.1016/S1015-9584(08)60032-9]26 Liu SY, Poon CM, Leung TL, Wong CW, Chan YL, Leung TC, Leong HT. Nurse-administered propofol-alfentanil sedation using a patient-controlled analgesia pump compared with opioid-benzodiazepine sedation for outpatient colonoscopy. Endoscopy 2009; 41: 522-528 [PMID: 19440955 DOI: 10.1055/s-0029-1214711]27 Sipe BW, Rex DK, Latinovich D, Overley C, Kinser K, Bratcher L, Kareken D. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc 2002; 55: 815-825 [PMID: 12024134 DOI: 10.1067/mge.2002.124636]28 Külling D, Rothenbühler R, Inauen W. Safety of nonanesthetist sedation with propofol for outpatient colonoscopy and esophagogastroduodenoscopy. Endoscopy 2003; 35: 679-682 [PMID: 12929064 DOI: 10.1055/s-2003-41518]29 Horn E, Nesbit SA. Pharmacology and pharmacokinetics of sedatives and analgesics. Gastrointest Endosc Clin N Am 2004; 14: 247-268 [PMID: 15121142 DOI: 10.1016/j.giec.2004.01.001]30 Hsu CD, Huang JM, Chuang YP, Wei HY, Su YC, Wu JY, Wang WM, Hsu HT, Huang HF, Lu IC, Lu DV. Propofol target-controlled infusion for sedated gastrointestinal endoscopy: A comparison of propofol alone versus propofol-fentanyl-midazolam. Kaohsiung J Med Sci 2015; 31: 580-584 [PMID: 26678938 DOI: 10.1016/j.kjms.2015.09.004]31 Heuss LT, Schnieper P, Drewe J, Pflimlin E, Beglinger C. Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients-a prospective, controlled study. Am J Gastroenterol 2003; 98: 1751-1757 [PMID: 12907329 DOI: 10.1111/j.1572-0241.2003.07596.x]32 ketamine (Rx) [cited 8 Nov 2018]. Available from: Ketamine Hydrochloride (Ketamine HCl) side effects drug center [cited 8 Nov 2018]. Available from: Shah A, Mosdossy G, McLeod S, Lehnhardt K, Peddle M, Rieder M. A blinded, randomized controlled trial to evaluate ketamine/propofol versus ketamine alone for procedural sedation in children. Ann Emerg Med 2011; 57: 425-33.e2 [PMID: 20947210 DOI: 10.1016/j.annemergmed.2010.08.032]35 Guit JB, Koning HM, Coster ML, Niemeijer RP, Mackie DP. Ketamine as analgesic for total intravenous anaesthesia with propofol. Anaesthesia 1991; 46: 24-27 [PMID: 1996747 DOI: 10.1111/j.1365-2044.1991.tb09308.x]P-Reviewer: de Quadros LG, Teramoto-Matsubara OTS-Editor: Dou Y L-Editor: E-Editor:Specialty type: Medicine, research and experimentalCountry of origin: TurkeyPeer-review report classificationGrade A (Excellent): 0Grade B (Very good): 0Grade C (Good): C, CGrade D (Fair): 0Grade E (Poor): 0Table 1 Patients’ demographic data n (%)EndoscopistAnaesthetistPmean ± SDMedianmean ± SDMedianAge53.6 ± 15.557.559.9 ± 11.862.00.1131SexFemale18 (60.0)17 (56.7)0.7932Male12 (40.0)13 (43.3)ASAI18 (60.0)11 (36.7)0.0712II12 (40.0)19 (63.3)1Mann-Whitney U test; 2Chi-square test. ASA: American Statistical Association.Table 2 Information of propofol consumption, durations (reaching the cecum, operation, and recovery), patient satisfaction, operation re-preference, and recall of the procedure n (%)EndoscopistAnaesthetistPmean ± SDMedianmean ± SDMedianPropofol consumption dose83.0 ± 57.170.059.7 ± 17.550.00.0141Reaching the cecum (min) 5.8 ± 4.95.54.9 ± 2.24.00.0041Total operation (min) 13.7 ± 7.213.09.5 ± 3.68.50.0221Eye opening/Recovery (min) 1.6 ± 1.21.02.0 ± 0.82.01.0001VAS0.5 ± 0.80.00.5 ± 0.90.00.8031Patient SatisfactionI19 (63.3) 12 (40.0) 0.0982II10 (33.3) 13 (43.3) III1 (3.3) 5 (16.7) Operation re-preference?30 (100.0) 28 (93.3) 0.4922Recall of the procedure(-) 27 (90.0) 27 (90.0) 1.0002(+) 3 (10.0) 3 (10.0) 1Mann-Whitney U test; 2Chi-square test. VAS: Visual analogue scale.Table 3 Hemodynamic changes during the procedureEndoscopistAnaesthetistP1mean ± SDMedianmean ± SDMedianPulse (beats per minute)Baseline82.8 ± 13.382.584.2 ± 11.785.50.6731st min81.4 ± 13.379.085.7 ± 14.684.00.2512nd min80.9 ± 13.879.083.5 ± 17.981.00.7163rd min80.8 ± 13.579.080.7 ± 19.279.50.7044th min81.0 ± 15.380.080.1 ± 18.577.50.6655th min81.9 ± 14.681.080.5 ± 18.878.00.414≥ 8th min81.1 ± 14.778.577.5 ± 14.475.00.336Systolic blood pressure (mm Hg)Baseline131.0 ± 20.5131.5136.1 ± 22.3135.00.4121st min126.2 ± 17.6121.0129.9 ± 19.4132.50.5792nd min124.2 ± 13.6125.0125.7 ± 29.5121.50.5193rd min123.4 ± 13.9122.0126.5 ± 27.9123.00.9524th min126.5 ± 15.9125.0131.8 ± 30.3129.50.4485th min123.8 ± 13.4122.0139.3 ± 28.7141.00.014≥8th min124.1 ± 17.2120.5142.3 ± 26.7141.00.003Diastolic blood pressure (mm Hg)Baseline73.2 ± 12.370.573.4 ± 13.474.00.8711st min70.6 ± 10.269.574.7 ± 14.074.00.1832nd min71.1 ± 11.171.072.9 ± 18.369.00.9883rd min71.2 ± 11.170.076.3 ± 18.275.50.3594th min72.8 ± 11.172.078.7 ± 17.980.50.1755th min69.2 ± 11.569.581.9 ± 17.282.00.002≥8th min73.2 ± 11.870.583.4 ± 16.882.00.005SPO?Baseline96.7 ± 1.997.094.4 ± 2.794.00.0001st min96.0 ± 2.897.094.7 ± 2.495.00.0142nd min96.5 ± 3.597.095.3 ± 2.295.50.0713rd min96.2 ± 2.897.095.9 ± 2.095.50.3074th min96.4 ± 2.397.096.3 ± 1.996.00.5025th min95.1 ± 5.397.096.1 ± 1.796.00.685≥8th min96.1 ± 2.397.096.0 ± 1.496.00.4221Mann-Whitney U test.Table 4 Side effects experienced by patients during the procedure n (%)EndoscopistAnaesthetistP1Cardio pulmonaryHypotension2 (6.7)2 (6.7)1.000Bradycardia1 (3.3)0 (0.0)1.000Desaturation4 (13.3)1 (3.3)0.161Other side effectsNausea and Vomiting0 (0.0)0 (0.0)1.000Headache2 (6.7)2 (6.7)1.0001Chi-square test. ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download